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DEVELOPMENT OF OLIGONUCLEOTIDE MICROARRAY FOR
HIGH THROUGHPUT DNA METHYLATION ANALYSIS

XIAOPENG LI

ABSTRACT

DNA methylation is a key event regulating gene expression. DNA methylation
analysis plays a pivotal role in unlocking association of epigenetic events with cancer.
However, simultaneous evaluation of the methylation status of multiple genes is still a
technical challenge. Microarray is a promising approach for high-throughput analysis of
the methylation status at numerous CpG sites within multiple genes of interest. In this
dissertation study, we conducted a systematic study to examine the use of microarray
methods for methylation analysis.
First, a robust universal microarray was established with more flexible in design
and content, and potential cost saving over commercial arrays. In order to produce high
quality microarray data, we optimized the attachment chemistry for the modified
oligonucleotides, searched for the good combination of fluorescent dyes, and
v

hybridization conditions. To improve the specificity of the microarray, we conducted a
study to experimentally search for a set of highly discriminative tag Sequences.
Second, SBE-TAGs microarray was successfully adapted from the SNP
detection for methylation analysis of multiple genes. SBE-TAGs microarray performed
quite well in multiplex methylation analysis of cell lines if a standard calibration curve
method was used. 10 CpG sites of 9 tumor suppressor genes (MGMT, GATA4, HLTF,
SOCS1, p16, RASSF2, CHFR, TPEF, and Reprimo) were selected for this study.
Third,

a

novel

method

called

CHZMA

(Competing-Hybridization-

Zipcode-MicroArray) was developed for methylation analysis of tumor tissue samples,
which is based on two steps of hybridization to achieve the specific detection of
methylation on microarray. On the basis of analysis of seven genes (MGMT, GATA4,
HLTF, SOCS1, RASSF2, ER, 3-OST-2), we found that the CHZMA assay can robustly
detect methylation of multiple genes in the samples containing as low as 10% of
methylated DNA. With the strict control group test and statistical analysis, CHZMA can
be a good high-throughput method in place of MSP for methylation analysis of tumor
tissue samples.
These studies provide reliable and robust tools for methylation analysis, and
could be used for cancer prognosis and diagnosis in the future.
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CHAPTER I

CURRENT DNA METHYLATION ANALYSIS METHODOLOGY

1.1 Introduction
1.1.1 DNA Methylation: the Major Form of Epigenetic Change in Genome
It is now clear that genetic and epigenetic are the two forms of information
included in genome. Genetic information provides the blueprint to manufacture all of the
proteins, while epigenetic information provides the instruction to use these proteins
(Robertson 2001). In the mammalian cell, methylation is a major form of epigenetic
change, which is modified by DNA methyltransferases (DNMTs) adding a methyl group
on the 5-position of cytosine within the CpG dinucleotide site (Doerfler 1983).
Approximately, 70-80% of CpG sites in the mammalian genome contain methylated
cytosines (Antequera and Bird 1993; Bird 1995). Methylated cytosines are widely spread
throughout the genome, predominantly in repetitive genomic regions, including satellite
DNA and parasitic elements (Yoder et al.1997). Unmethylated CpG sites are primarily
1

confined to DNA regions with high relative densities of CpG, called CpG islands,
ranging from 0.5 to 5 kb and occurring on average every 100 kb (Bird 1986;
Gardiner-Garden and Formmer 1987). Recently, it is estimated at least 29, 000 CpG
islands in the human genome (Lander et al. 2001; Venter et al. 2001), are distributed in a
non-random pattern, particularly in the promoters and the first exon regions of protein
coding genes (Bird 1986).
DNA methylation is a crucial epigenetic alteration, involved in embryonic
development, transcription, chromatin structure, X chromosome inactivation, genomic
imprinting and chromosome stability. In the normal cell, most CpG islands remaining
unmethylated are associated with transcriptionally active genes, and some CpG islands
were found normally methylated in imprinted genes (Li et al. 1993; Paulsen and
Ferguson-Smith 2001), X chromosome inactivation genes (Panning and Jaenisch 1998),
and parasitic DNA suppression genes (Walsh et al. 1998). Whereas DNA methylation is a
crucial mechanism to regulate the genetic information, it also adds an additional burden,
such as abnormal methylation was found in human carcinogenesis.
1.1.2 DNA Methylation and Cancer
As the two major forms of methylation, genome-wide hypomethylation and
region-specific hypermethylation have been broadly found in carcinogenesis. In human
carcinogenesis, the hypermethylation in promoters will repress transcription via the
inhibiting the binding of specific transcription factors directly, or via local changes in
histone modification and chromatin structure by methyl-CpG-binding proteins indirectly
(Robertson

2005).

In

contrast,

the

biological

significance

of

genome-wide

hypomethylation in the repetitive regions is less understood. However, global
2

measurements of DNA hypomethylation remain a valuable tool for understanding the
molecular pathology of human cancer, and for monitoring therapeutic responses to
potential compounds in human clinical trials. It is clear that DNA hypomethylation can
foster chromosome instability (Ehrlich 2002; Eden et al. 2003), increase the mobility of
transposable elements (Walsh et al. 1998), and induce tumorigenesis in different mouse
models (Eden et al. 2003; Gaudet et al. 2003; Yamada et al. 2005; Jones and Baylin 2007).
In addition, the correlation between hypomethylation and increased gene expression was
reported for many oncogenes (Feinberg and Vogelstein 1983; Hanada et al. 1993).
In cancer, promoter hypermethylation is associated with gene silencing, and
together with point mutations and deletions, serves as one of the most common
mechanisms for the loss of function of tumor suppressor genes (Baylin et al. 1998;
Costello and Plass 2001; Jones and Baylin 2002; Robertson 2001; Robertson2005).
Because of the importance of hypermethylation in carcinogenesis, a growing number of
studies have provided fundamental insights into cancer development. In virtually every
type of human neoplasm, promoter methylation is found to be associated with
inappropriate transcriptional silencing of genes (Costello et al. 2000; Toyooka et al. 2001;
Rashid et al. 2001; Martens et al. 2005; Sato et al. 2005; Kusano et al. 2006). As DNA
methylation is more readily reversible than genetic events, DNA hypermethylation in
promoter is emerging as a potential diagnostic and prognostic tool (Karpf and Jones
2002).
1.1.3 DNA Methylation Analysis
DNA methylation research can be approached from a wide range of techniques.
Each technique has its own peculiarities to offer a different perspective for occurrence
3

and localization of methylation in the genome. In this chapter, a summary of the most
commonly used techniques will be provided for methylation research, in particularly for
hypermethylation analysis. A general outline of the principles, advantages, and
disadvantages of these techniques will be discussed in each section. The current methods
can be broadly classed into two major approaches: global methylation analysis
(genome-wide); and site-specific methylation status determination (Oakeley 1999; Fraga
and Esteller 2002; Laird 2003). In the following, all of the methods will be grouped into
these two categories (Fig. 1). In global methylation analysis, high-performance separation
(HPLC and HPCE), enzymatic reaction, chemical reaction, and immunology-based
methods will be discussed. In site-specific methylation analysis, the methods are divided
into two subcategories, bisulfite and non-bisulfite treatment. For the non-bisulfite
methods,

we

focused

on

the

application

of

methylation-sensitive

and

methylation-insensitive restriction endonucleases. For the bisulfite treatment methods, a
series of methods including sequencing, methylation-specific PCR (MSP), quantitative
MSP (QMSP), single base extension, ligation, fragment analysis, and microarray et al.,
will be discussed.
1.2 Global Methylation Analysis
1.2.1 Reverse-Phase HPLC (RP-HPLC)
Global genomic DNA methylation status can be determined by reverse-phase HPLC
using chemical or enzymatic hydrolysis of DNA. In the chemical hydrolysis, DNA is
incubated in formic acid (Eick et al. 1983) or hydrofluoric acid (Catania et al. 1987).
After the hydrolysis, liberated cytosine, thymine, guanine, adenine, and 5-methylcytosine

4

Fig. 1 The methods of DNA methylation analysis. The existing methylation analysis
methods are assorted into global and site-specific analysis. The site-specific analysis
includes two categories: non-bisulfite and bisulfite analysis. MSP: methylation-specific
PCR; SBE: single base extension.

5

are subsequently separated and determined by reverse-phase HPLC. Since the
deamination of cytosine and 5-methylcytosine occurs during the hydrolysis procedure
using formic acid, quantitation of 5-methylcytosine in DNA is not as accurate as
hydrofluoric acid is used in hydrolysis.
As an alternative, enzymatic hydrolysis presents more power in quantitative
methylation

analysis.

The

2’-deoxymononucleosides,

DNA

using

sample

DNase

I,

is

the

Nuclease

hydrolyzed
P1,

or

to

produce

snake

venom

phosphodiesterase, followed by alkaline phosphatase treatment (Kuo et al. 1980; Ehrlich
1982; Gomes and Chang 1983). The liberated 2’-deoxymononucleosides are separated
and detected by standard HPLC-UV system, which can detect 2–10% of the
5-methylcytosine (m5C) (Kuo et al. 1980; Wagner and Capesius 1981; Gama-Sosa et al.
1983). HPLC operating with fluorescence detection can provide a 10-fold higher
sensitivity, but has drawbacks with tedious labeling procedures (Sonoki et al. 1998; Wirtz
et al. 2004).
Recently, with the utilizing of HPLC-MS system, the sensitivity of methylation
detection has been greatly improved. Babinger and co-workers used RP-HPLC combined
with electrospray mass spectrometry (ESI-MS) to analyze Volvox DNA. As little as 1.1%
of 5-methylcytosine was detected in total deoxycytidine residues of genome (Babinger et
al. 2001). Friso also detected about 1.7-1.9% of 5-methylcytosine in total deoxycytidine
with <1μg DNA sample, using HPLC-ESI system (Friso et al. 2002). However, RNA
contamination of the DNA sample could cause the quantification to fail, as ESI-MS was
incapable of distinguishing 5-methyl-2’-deoxycytidine from 5-methyl-2’-cytidine (Havlis
and Trgbusek 2002). Alternatively, Sony et al. have developed a highly specific and

6

sensitive assay with tandem mass spectrometry (Song et al. 2005). With this
HPLC-ESI-MS/MS system, methylation levels ranging from 0.05 to 10% can be detected
in 4 ng of DNA. This detection sensitivity should permit the use of this method for
applications having limiting amounts of DNA in clinical samples.
1.2.2 Thin-Layer Chromatography (TLC)
The TLC was initially reported for separation and determination of
5-methyldeoxycytosine (m5dC) in 1981 (Wagner and Capesius 1981). In this assay, the
restriction enzyme MspI cuts the target site CCGG regardless of whether cytosine is
methylated or not. Bestor and Schmitt groups labeled the internal cytosine with [32P]ATP
and polynucleotide kinase, then hydrolyzed the nucleotides with nuclease P1 to
individual nucleotides, which is separated on 1-D or 2-D cellulose thin-layer
chromatography plates (Bestor et al. 1984; Schmitt et al. 1997). In Leonard and Gowher
studies, the nucleotides were digested to individual nucleotides, which are separated by
RP-HPLC to isolate both m5dC and dC. Then, the individual m5dC and dC were labeled
with [32P]ATP and polynucleotide kinase. Finally, the 1-D or 2-D TLC was used to
identify the methylation status (Leonard et al. 1993; Gowher et al. 2000). This sensitive
assay could detect the presence of m5C in genomic DNA at the level of 1 in 1000-2000
cytosine residues (Leonard et al. 1993). One of the shortcomings of this method is that
digesting the nucleotides to produce individual m5dC and dC prior to the labeling makes
the dC much easier to label than m5dC. This will reduce the detection limit of m5dC in
genomic sample. In addition, noisy signals from A, G, and T were observed on the TLC
plates (Oakeley 1999).

7

1.2.3 High Performance Capillary Electrophoresis (HPCE)
Two major modifications of capillary electrophoresis: micellar-electrokinetic
capillary chromatography and capillary zone electrophoresis, are frequently used in
global methylation analysis. Fraga et al. has reported a new open-tube capillary
electrophoresis system to separate the acidic/enzymatic hydrolyzed genomic DNA for
methylation analysis. The dC and m5dC were successfully separated in SDS
micellar-electrokinetic system with UV detection (Fraga et al. 2000). In contrast to HPLC,
HPCE does not need specific running buffer, and is faster than HPLC with 10min/sample.
The limitation of detection is one m5dC in 200 dC, using a 1μg DNA sample. Sandoval
Guerrero et al. optimized this system to more efficient peaks, a flatter base line, and
shorter analysis time with employing a fused-silica capillary (75 mm inner diameter) of
44.5 cm effective length, 20 mM carbonate buffer (pH 9.6) plus 80 mM sodium dodecyl
sulfate (Sandoval Guerrero et al. 2005). To overcome the limitation of the UV detection
at 280 nm, Schmitz’s group developed a laser-induced fluorescence detection system to
improve the sensitivity (Lyko et al. 2004; Wirtz et al. 2004). In the assay, the hydrolyzed
mono-nucleotides, including dC and m5dC, were modified with fluorescent dye (Bodipy
FLEDA), then separated in micellar-electrokinetic chromatography and detected with the
laser-induced fluorescence system. After optimization, the method can determine the
methylation level in 100-ng DNA samples (10 folds better than UV) with a standard
deviation of less than 5%, suitable for clinical sample testing.
Recently, a new capillary zone electrophoresis method applying short-end
injection technique was reported (Sotgia et al. 2008). By injecting the sample at the
capillary end, closest to the detector window, the migration distance of analytes is
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significantly reduced to10.2 cm. Thus, dC and m5dC after acid hydrolysis were separated
with a good resolution in less than 1.5 min, which is much shorter than normal injection
with 6-10min. The lowest amount of DNA required to evaluate methylation is about 0.5
μg.
1.2.4 Enzymatic Method
In vivo, SssI methyltransferase (CpG methylase) catalyses the transfer of a
methyl group from S-adenosyl-L-methionine (SAM) to C5 of cytosine within CpG
dinucleotide sequences in genomic DNA shortly after DNA replication (Baylin 1997).
Under this mechanism, SssI methyltransferase based enzymatic methods were developed
for methylaiton analysis (Adams et al. 1991; Balaghi et al. 1993; Wu et al. 1993;
Belinsky et al. 1995; Schmitt et al. 1997). In this assay, [Methyl-3H]SAM is used as a
substrate to incorporate into all of the unmethylated cytosines in CpG sites of genomic
DNA under the catalyses of SssI methyltransferase. After that, the labeled DNA is
collected on filter paper, washed, and counted in a scintillation counter. The amount of
incorporated radioactive Tritium is proportional to the unmethylated level of the DNA
sample. Due to the crude or semipurified preparations of SssI methyltransferase, RNA
and protein remaining in genomic DNA may possibly be labeled with [Methyl-3H]SAM
in the presence of other methyltransferases to yield artificial results. Furthermore, the
nonspecific absorption of radioactivity in the precipitates can also yield error results
(Chiang et al. 1996). Fiala et al. developed a modified SssI methyltransferase assay for
hypomethylation analysis in tissue samples, using HPLC with radioflow detection after
enzymatic hydrolysis, enhancing specificity and reliability (Fiala et al. 1998). The
problem with the SssI methyltransferase assay is the handling and disposal of Tritium.
9

1.2.5 Chemical Method
Oakeley et al. developed a method to label any m5dC in genomic sequence with
sodium bisulfite and chloracetaldehyde reaction (Oakeley et al. 1999). First, the genomic
DNA was subjected into bisulfite treatment, which coverted all of dC into dU, while
having no effect on m5dC (Frommer et al. 1992). Second, using sulphuric acid, bisulfite
treated DNA was depurinated to eliminate 99% of dA, which was precipitated with silver
nitrate. The supernatant was incubated with chloracetaldehyde to form ethenocytosine
(derivative of m5dC), and residual ethenoadenine (derivative of dA). Both of these two
derivatives are intensely fluorescent and with two different major peaks. Only dA, dC,
and m5dC can react with chloracetaldehyde. Hence, the bisulfite conversion and dA
removal are critical to the assay. After the fluorescence scanning, the methylation signal
was

determined

by

removing

the

contamination

of

ethenoadenine.

As

the

chloracetaldehyde is quite toxic, special care must be taken in the labeling and
detoxification.
Recently, Okamoto group reported a m5dC-selective reaction with potassium
osmate, functional bipyridine, and potassium hexacyanoferrate (III) (Okamoto et al. 2006;
Tanaka et al. 2007 a, b). This osmate reaction distinguished m5dC and dC with high
selectivity. All of the study of this new method is focused in site-specific methylation
detection with a hybridization probe. But this reaction has great potential for global
methylation analysis, if combined with other techniques. Chemical based analysis, as a
good alternative mean, can detect any m5dC in the genomic DNA.

10

1.2.6 Immunological Method
Using monoclonal antibodies directed against m5C is another approach for
global DNA methylation analysis. Podestà et al. described the preparation and basic
properties of monoclonal IgG1 (Podestà et al. 1993), whose specificity was validated by
using methylated and unmethylated oligonucleotides (Oakeley et al.1997) In this assay, a
DNA sample is immobilized on the DEAE membrane, then incubated in monoclonal
IgG1, followed by incubating in the secondary antibody of FITC-labeled goat anti-mouse
IgG for fluorescence scanning (Oakeley et al.1997; Zluvova et al. 2001). The methylation
level is proportional to the intensity of the fluorescent signal on the membrane. The
amount of DNA loaded on membrane is measured by ethidium bromide fluorescence
staining after the fluorescent scanning.
The outstanding feature of immunology assay is to visualize the chromosomal
methylation patterns by fluorescence microscopy on a cell-by-cell basis. The DNA in
chromosomes can be labeled only when m5dC is not base-paired. In the early research,
UV light, alkali, or heat treatment was used for long time denaturation of chromosome
(Miller et al. 1974; Barbin et al. 1994; Montpellier et al. 1994; Rougier et al. 1998). After
the denaturation, the mono-antibodies combined with fluorescence dye were incorporated
into chromosome. Due to the disruption of chromosome structure in the denaturation,
gentle conditions were used in denaturation with a short UV light exposure (three hours)
at a low temperature (4oC) (Bensaada et al. 1998). This method can be used to determine
the methylated status of chromosomes, and to map not only the structural (banding) but
also the functional (methylation status) properties of the different chromosome domains
in cells.

11

1.3 Restriction Analysis for Site-Specific Methylation Detection
Methylation-sensitive

digestion

combined

with

insensitive

restriction

endonucleases provide a simple tool for methylation analysis of large quantities DNA. As
the most common isoschizomers, HpaII and MspI are used to cleave the DNA at CCGG
target, where HpaII is not able to cut the sequence when m5dC is present in the CpG site
(Cedar et al. 1979; Singer et al. 1979; Bird 1980). The DNA samples are digested by
HpaII and MspI, respectively. Then, the different size of the digests will be revealed on
Southern blot by hybridizing with radio isotope labeled probe. If the HpaII and MspI
digests have the same size hybridized bands, the target site covered by probe is
unmethylated. In the contrast, if the hybridized bands of HpaII are bigger than MspI, the
target site is methylated. To improve the sensitivity, PCR was used to amplify the digests
(Singer-Sam et al. 1990). The PCR amplification region must contain single CCGG or
more. If the CCGG is methylated, only DNA digested with HpaII can be amplified, and
no PCR amplification is from MspI digests. If the CCGG is unmethylated, both of HpaII
and MspI digests can not amplify with the cleaved templates. For PCR detection, less
than 10ng DNA is required for digestion, whereas 10μg is required for Southern blot
detection. Furthermore, 1 m5dC in 1000 dC is able to be detected (Kutueva et al. 1996).
Although this method is straightforward, some problems arise from the limitation of
restriction sites, false-positives caused by partial digest, and the high molecular weight
DNA requirement.
Recently, Methylation-specific multiplex ligation-dependent probe amplification
(MS-MLPA) was reported to detect 40 sequences simultaneously, using only 20ng of
DNA (Nygren et al. 2005). In the assay, the methylated and unmethylated DNA samples
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were denatured and hybridized with one pair of ligation probes with universal sequence,
followed by simultaneously ligated and digested with ligase and methylation sensitive
endonucleases. The ligated unmethylated sequence was cleaved by methylation sensitive
endonucleases, and could not be amplified by universal primers. The ligated methylated
sequence remained intact as a template for PCR amplification. The PCR products with
different sizes were measured by fragment analysis.
Restriction landmark genomic scanning (RLGS) is another restriction enzyme
based method, which can evaluate over 2000 loci simultaneously with two-dimensional
gel electrophoresis of digested genomic DNA (Hatada et al. 1991). In the methylation
analysis, DNA is digested with methylation-sensitive enzyme, like NotI (GCGGCCGC)
or AscI (GGCGCGCC), and directly labeled with a radioactive isotope. Methylated sites
are not digested and are therefore not labeled, thus they do not contribute to the
two-dimensional pattern of RLGS fragments. The DNA samples require the high-quality,
high-molecular-weight to prevent nonspecific labeling of degraded fragments. After the
first restriction digest with methylation-sensitive enzyme, the DNA is subjected to the
second restriction to produce short strands for the first-dimension electrophoresis with
0.8% agarose gel. Following that, DNA in agarose is restriction digested at 3rd time to
produce shorter strands for second-dimension electrophoresis in a large 5% acrylamide
gel. Finally, the digested sites from the unmethylation sequence display with
corresponding spots with the autoradiography. With the control profiles from normal
group, they can determine the absent spot, which results from the failure of
methylation-sensitive digest and represents the methylation site in the sample (Shibata et
al. 1995; Akama et al. 1997; Costello et al. 2000; Matsuyama et al. 2003). Although
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RLGS is highly reproducible, the assignment of specific genomic sequences to RLGS
spots is still a challenge. Plass and co-workers set up the standard data system, called
Master profile, for each locus assignment (Smiraglia and Plass 2002; Rusha and Plass
2002). With the completion of the human and mouse genome sequences, a virtual RLGS
profile based on the bioinformatics approach became available for RLGS fragment
identification. In the virtual RLGS profile each restriction fragment's migration in both
dimensions could be predicted (Rouillard et al. 2001; Smiraglia et al. 2007). As much,
RLGS has become a versatile tool in hypomethylation and hypermethylation analysis for
normal tissues, primary tumors, and cancer cell lines in various organisms.
1.4 Bisulfite-Based Methods for Site-Specific Methylation Detection
1.4.1 Bisulfite Conversion
The analysis of DNA methylation was revolutionized by sodium bisulfite
conversion, which permits the indentification of any CpG sites in the genome, rather than
the specific sequences targeted by restriction endonucleases. The different conversion
rates of cytosine and 5-methylcytosine deaminated by sodium bisulfite to yield uracil and
thymine were described in 1970s (Hayatsu et al. 1970; Shapiro et al. 1970; Hayatsu and
Shiragami 1979). This converstion did not get much attention until Frommer et al. used it
to distinguish the dC and m5dC. The breakthrough in this area is that bisulfite converts all
of dCs to uracils whereas the m5dC residues remain intact. Then, the treated DNA is
subjected to PCR amplification to yield fragments wherein Ts replace Us (former Cs),
and Cs replace the methylated Cs (Frommer et al. 1992). Based on this conversion, DNA
methylation research can be approached from a wide range of techniques, including
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sequencing, methylation-specific PCR, combined bisulfite restriction assays, microarray,
and others (Fig. 2).
In the bisulfite treatment, the incomplete conversion of dCs will cause
false-positive results. To prevent the non-converted dCs, special attention should be paid
for DNA denaturation, desulfonation, bisulfite sodium concentration, and reaction
conditions, whereas, 84-96% of the DNA is degraded under this condition (Grunau et al.
2001). More significant losses are found during the subsequent reaction and purification
for short strand DNA, thus more than 99% of DNA can be degraded (Munson et al. 2007;
Tanaka and Okamoto 2007).
As the bisulfite conversion is susceptible to processing errors, several attempts
have been made to simplify the treatment. Raizis et al. reported that using high
concentration (5M) of sodium bisulfite can reduce the degradation with 4h incubation
(Raizis et al. 1995). Olek et al. performed the bisulfite treatment and subsequent PCR
steps with low melting point agarose beads, in which the denatured DNA will be kept in
single strand form to avoid strand annealing (Olek et al. 1996). The single strand DNA
improves the reaction efficiency, and reduces the reaction time to 4h. On the other hand,
the subsequent reaction and purification of bisulfite converted DNA within agarose beads
will be gentle to reduce the DNA strand cleavage. With these two modifications, 500 pg
of starting DNA can provide reliable PCR products. Many research works focused on
clinical specimens rely on this agarose beads based method to improve the recovery of
bisulfite treated DNA, in particularly in tiny tissue and serum specimens, which often
provide less than 50ng DNA (Kitazawa et al. 2000; Kim et al. 2005; Peng et al. 2006). To
reduce the matrix binding loss in the desulfonation and purification, centrifugal filtration
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Fig. 2 Bisulfite conversion. (A) In the bisulfite treatment, only normal cytosine is
converted to uracil, and 5-methylcytosine is intact. (B) The treated DNA is amplified in
PCR to generate fragments wherein Ts replace Us (former Cs), and Cs replace the
methylated Cs. These sequence variation can be analyzed using conventional SNP or
mutation analysis methods.
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was used to provide a simplified, high-recovery procedure that lends itself to increased
throughput and can be applied to 300 pg starting DNA (Boyd and Zon 2004). Recently,
the molecular diagnostic researchers target the tumor-derived short strand DNA in
samples such as blood (Cottrell and Laird 2003; Lofton-Day et al. 2008), urine (Westra et
al. 2006; Yu et al. 2007), sputum or saliva (Konno et al. 2004) and stool (Chen et al. 2005;
Zhang et al. 2007; Wang and Tang 2008). However, the degradation of the tiny DNA in
bisulfite treatment is still a big challenge to improve the sensitivity and specificity.
1.4.2 Sequencing
Bisulfite sequencing genomic DNA is the most common method in methylation
analysis. The PCR primers are designed without CpG sites contained in their sequence to
ensure unbiased amplification of both methylated or unmethylated DNA. After the PCR
amplifies, the PCR product can be subjected for the direct sequencing, or subcloning
followed by sequencing the subclones (Frommer et al. 1992). The direct sequencing is
fast, simple, and may better reveal the overall methylation status of the DNA sample. The
human epigenome project in Europe used direct sequencing of bisulfite PCR products
(Rakyan et al. 2004; Eckhardt et al. 2006). In this method, the methylation status of any
given CpG site is the average of all amplicons generated during PCR. Sequencing the
subcloned PCR products is time consuming, but can deliver the methylation patterns of
individual molecules. This provides a better understanding of complex pattern of
methylation such as monoallelic methylation and incomplete allele methylation. Because
of the DNA methylation patterns with the ability to reflect different functions of the DNA
methylation system (Colot and Rossignol 1999), sequencing of subclones has been used
to study cancer related methylated genes such as APC (Esteller et al. 2000), Rb (Stirzaker
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et al. 1997), TMS (Levine et al. 2003), and RASSF1A (Peters et al. 2007).
As alternative sequencing to conventional chain termination sequencing (Sanger
et al. 1977), pyrosequencing holds great promise for both confirmatory sequencing and
de novo sequencing (Ronaghi et al. 1996; Ronaghi et al. 1998). Pyrosequencing is a
sequencing-by-synthesis technique based on the detection of released pyrophosphate (PPi)
during DNA synthesis. With ATP sulfurylase, the released PPi is subsequently converted
to ATP, which provides the energy to luciferase to oxidize luciferin and generate light.
The intensity of the light is proportional to the number of incorporated nucleotides and
the sequence is determined by added nucleotide in the cycling reaction.
However, this technique has not been used for genome sequencing due to the
short read length about 1-300 nucleotides (Mashayekhi and Ronaghi 2007). The
interesting thing is that this limitation makes pyrosequencing suitable for bisulfite treated
DNA with short strands (Uhlmann et al. 2002). Moreover, since pyrosequencing works
better on small PCR products (100-150 bp), it provides good resolution for clinical or
archival sample with partial degraded DNA, which is a big problem with other techniques
(Colella et al. 2003; Tost et al. 2003; Shaw et al. 2006). Recently, a novel parallel
pyrosequencing in microfabricated high-density picolitre reactors was developed by 454
sequencing (Margulies et al. 2005). With this new platform, around 300,000 DNA
templates with 100 bp length can be simultaneously sequenced in 5.5 h with an accuracy
of 99.6%. This technology provides high-throughput and ultradeep methylation analysis
for multiple tumor types, and multiple genes. Taylor et al. described the methylation
pattern analysis of 294,631 DNA fragments with an average read length of 131bp from
25 gene-related CpG rich regions in more than 40 primary cells (Taylor et al. 2007).
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Korshunova et al. reported the methylation patterns of more than 700,000 DNA
fragments derived from breast tissues and circulating DNA in more than 50 individuals
(Korshunova et al. 2008).
1.4.3 Methylation-Specific PCR
Methylation-specific PCR (MSP) is the most common used method for
methylation analysis, because of its high sensitivity and simplicity (Herman et al. 1996).
The differences of methylated and unmethylated sequences derived from bisulfite
conversion are the basis of MSP, in particularly in CpG islands. MSP reveals the
methylation status of the CpG sites within the two short sequences targeted by MSP
primers. Hence, the primer design is crucial to the discrimination power of MSP, where
methylation-specific and unmethylated DNA-specific primers cover the same CpG sites
and yield different PCR products, respectively.
To avoid the labor-intensive gel electrophoresis after the MSP, Lo et al. and Eads
et al. adopted the fluorescence-based real-time PCR (TaqMan) for high-throughput
quantitative MSP (QMSP), which was highly sensitive and can detect one methylated
allele in 10,000 copies of unmethylated alleles (Lo et al. 1999; Eads et al. 2000). In this
QMSP, the methylation level was calculated by dividing the methylated signal with the
sum of methylated signal and unmethylated signal. Sidransky and co-workers simplified
this QMSP using the unique internal reference gene such as MyOD1 (Jerónimo et al.
2001), and ACTB (Harden et al. 2003; Hoque et al. 2006), which do not have CpG sites
in their sequence. The ratio of signal from methylated amplification to internal reference
was used to measure the relative methylation level of the target gene. In this simplified
QMSP system, only the primers for methylated allele were contained, but no primers for
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unmethylated allele.
However, MSP is prone to false-positive because of the low discrimination of
primers, especially in incompletely converted sequences in the bisulfite- treated DNA
(Aggerholm et al. 2000; Rand et al. 2002). To avoid the false-positive results caused by
non-specific amplification, sensitive melting analysis after real time (SMART)-MSP was
reported for sensitive DNA methylation detection based on probe-free real-time PCR
(Kristensen et al. 2008). In this assay, the false-positive results due to incomplete bisulfite
conversion or false priming can be identified by high-resolution melting.
1.4.4 Single Base Extension
Gonzalgo et al. first used the single base extension (SBE) for quantitative
methylation analysis of individual CpG sites using bisulfite-PCR products (Gonzalgo and
Jones 1997). SBE is then performed with oligonucleotides designed to hybridize
immediately upstream of the CpG site being interrogated. The product can be detected by
the adding radioactive ddC/ddT (ddG/ddA) on polyacrylamide gels. Several new
detection methods have been developed to improve the performance. Based on the
different masses and hydrophobicities of incorporated ddNTP, the methylated and
unmethylated CpG sites can be discriminated and quantified by ion pair reverse phase (IP
RP) HPLC (El-Maarri et al. 2002). Using this method, several CpG sites contained in
different SBE products can be measured simultaneously with high reproducibility. Dye
labeled ddNTPs are reported for the SBE reaction, followed by capillary electrophoresis
with ABI Prism® 3100 Genetic Analyzer (Applied Biosystems, CA) (Hong et al. 2005;
Kaminsky et al. 2005). In this method, the first discrimination is to use
methylated-specific and unmethylated- specific primers with different length but
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covering the same CpG sites to anneal the template. The second discrimination is the
SBE reaction with different dye labeled ddNTPs. After the electrophoresis, the peaks of
methylated and unmethylated primers with extension will show at different positions.
Since MALDI-TOF mass spectrometry combined with primer extension has
been shown to be a powerful tool in SNP analysis, Schatz et al. described the
combination of MALDI-TOF and primer extension for methylation analysis (Schatz et al.
2003). In the assay, the extension with α-S-ddNTPs results in a product with a
phosphorothioate backbone. After SBE, the part of the primer containing regular
phosphate bonds is digested off with

5'-phosphodiesterase, while the first

phosphorothioate group from the 5'-end inhibits the digestion of the product. Finally the
phosphorothioate functions are measured by MALDI-TOF.
In chapter IV, we will present our study with SBE based microarray for
high-throughput analysis of multiple genes, and multiple CpG sites.
1.4.5 Ligation
Recently, with bisulfite treatment, two ligation-based microarray methods were
developed for methylation analysis (Bibikova et al. 2006; Cheng et al. 2006). In the first
method, Barany and coworkers developed a PCR/LDR method for methylation analysis
(Cheng et al. 2006). Briefly, it first utilizes multiplexed PCR to amplify multiple target
DNA sequences, followed by ligation chain reactions, where methylated-specific and
unmethylated-specific probes modified with two different dyes (Cy3/Cy5). The ligation
products are then analyzed using microarray to determine the methylation status at each
target CpG site via the different fluorescence signals.
In the second method, Fan and his team from Illumina apply a genotyping
21

system to methylation analysis (Bibikova et al. 2006). Fan’s approach first utilizes
extension and ligation to produce both methylated and unmethylated alleles, followed by
multiplexed PCR with fluoresce labeled universal primers to amplify the sequences
containing the target CpG site. The methylation status at each CpG site is analyzed using
microarray. In Fan’s method, in order to improve the specificity, a gap (1-20bp) was
designed between the ligation probes. This gap can be filled by extension of DNA
polymerase. Ligation-based microarray improves specificity, allowing for methylation
analysis of cancer cell lines or tumor tissues that contain high abundance of tumor cells.
However, it is still not a robust method for methylation analysis of tumor tissues that
contain a minority of tumor cells. This is because the specificity of annealing a probe to a
given sequence varies greatly from one sequence to another (Dahl and Guldberg 2007).
1.4.6 Fragment Analysis
Fragment analysis as the most straightforward method was developed by Boyd
et al. from ABI (Applied Biosystems, CA) (Boyd et al. 2006). In this assay, amplicons
with different size bisulfite-converted DNA are analyzed immediately after multiplex
PCR with fluorescence labeled primers. In gel-capillary electrophoresis, methylated
amplicon migrates faster than the unmethylated amplicon. The PCR products of
methylated allele and unmethylated allele can be separated due to the accumulation of
several cytosines or thymines in the amplicons, respectively. Furthermore, this assay can
be used for quantitative analysis the overall methylation level in the selected area. To
improve the resolution of methylated and unmethylated peaks due to presence of only a
few CpG sites, the modified dCTP is incorporated in the PCR (Boyd et al. 2007). This
modified dCTP incorporated in PCR products allows for the detection of single C/T
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difference derived from single CpG after bisulfite conversion. The only problem with this
method is the methylation status can not be assigned to every CpG site in PCR product
with multiple CpG sites. But this direct analysis of bisulfite-converted PCR products
without any additional sample processing provides a robust tool for high-throughput
quantitative methylation analysis, in particular for the hypermethylation analysis in CpG
islands.
1.5 Conclusion
DNA methylation is a crucial epigenetic change and is involved in regulating
many cellular processes, particularly in relation with gene silencing in disease. Consistent
with these important roles, a growing number of methylation detection techniques have
been developed to provide fundamental insights into DNA methylation. In this short
review, some representative techniques have been introduced to address global and
site-specific methylation analysis. Each technique has its own peculiarities to provide a
unique approach for a specific problem. In some cases, DNA methylation analysis will
combine several methods together to get reliable results. Microarray as an alternative has
been widely used in methylaiton detection. Since the microarray application in
methylation is the major study of this project, the different platforms of microarray
related to methylation analysis will be described in detail in chapter II.
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CHAPTER II

HIGH-THROUGHPUT DNA METHYLATION PROFILING USING
MICROARRAY

2.1 Introduction
DNA microarrays are miniature arrays of DNA fragments attached to solid
supports, enabling a simultaneous analysis of a large amount of genetic information. Two
major forms of microarray were developed by fixing a target DNA fragment or detecting
oligonucleotide probes. The first form of microarray was evolved from Southern blotting,
whereby oligonucleotide probes are attached to a substrate and then hybridized with the
target DNA fragments (Southern et al. 1992). In the second form, Drmanac and
co-workers immobilized target DNA on the solid support first, then hybridized with
oligonucleotide probes (Drmanac et al. 1989; Drmanac et al. 1993). At the beginning, the
microarray was used for quantitative monitoring of gene expression, where thousands of
genes were evaluated simultaneously (Schena et al. 1995). Then, different platforms of
microarray were developed for mutation and SNP analysis, including direct hybridization
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(Chee et al. 2005; Kinoshita 2007), and ligation (Gunderson et al. 1998; Gerry et al. 1999;
Broude et al. 2001; Hashimoto et al. 2005). Inspired by the success of microarray on
mutation and SNP analysis, many investigators adapted these microarray platforms to
methylation analysis. In general, two major steps were involved in methylation research.
The first step is to identify new methylation markers using gene expression (Suzuki et al.
2002; Sato et al. 2003). The second step is to determine which genes among the candidate
makers discovered in the first step are silenced by methylation and how they are
associated with cancer or other diseases with microarray. Microarray-based methylation
profiling techniques have been categorized into three types: bisulfite conversion based
method, restriction enzyme cleavage based method, and immunology based method. In
this chapter, the several major platforms of microarray will be reviewed for methylation
profiling.
2.2 Bisulfite Conversion Based Microarray
2.2.1 Methylation-Specific Oligonucleotides Microarray
In the methylation-specific oligonucleotides (MSO) microarray, methylated and
unmethylated probes are designed from target DNA sequences with CpG sites, and
immobilized on a solid support. This pair of methylated and unmethylated probes was
hybridized with bisulfite PCR products via perfect match to evaluate the methylation
status of a DNA sample (Adorjâan et al. 2002; Balog et al. 2002; Gitan et al. 2002). This
direct hybridization based microarray potentially allows for rapid screening of the
methylation status at numerous CpG sites within one or multiple genes of interest. After
the bisulfite treatment and PCR, all Cs (not 5mCs) are replaced by Ts. This conversion
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creates a nearly C-less sequence of mostly 3-base-DNA having predominantly A, G, and
T (~50%). The reduction in sequence complexity facilitates the non-specific
hybridization between probes and targets (Tusnady et al. 2005). The investigator
developed strict criteria for probe selection, but the cross-hybridization of
imperfect-match between probes and targets was still observed. Mund and co-workers
tried 876 probes for the methylation analysis of P16 gene, and only 22 high
discriminative probes were found to be good enough for the analysis at last (Mund et al.
2005). The challenge is to select suitable sequences as probes with similar melting
temperatures. Furthermore, to improve the specificity of hybridization, two or more CpG
sites are included in one probe, which may lack the sensitivity to distinguish partially
methylated sequences from fully methylated or unmethylated DNA. These limitations
make it impossible to use MSO microarray for high-throughput methylation analysis.
Although additional work was done to improve the specificity of hybridization by
designing better probes (Kimura et al. 2005; Piotrowski et al. 2006), direct
hybridization-based microarray is still not sufficiently robust for methylation analysis.
The use of peptide nucleic acid (PNA) hybridization probes has been claimed to
enhance the hybridization stability and sensitivity, but with this modification, the base
composition and sequence influence the stability of the duplex (Griffin et al. 1997; Song
et al. 2005). The high cost ($600/probe) is also another limitation for using PNA in large
panels of microarray.
2.2.2 Ligation Based Microarray
Recently, two ligation-based microarray methods were developed for
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methylation analysis (Bibikova et al. 2006; Cheng et al. 2006). Both of these two
approaches use bisulfite conversion to create the C/T mutation sites for methylation
research. The only difference between these two methods is PCR first or ligation first. In
the first method, Barany and coworkers used traditional mutation and SNP detection
method, PCR/Ligation, for multiplexed profiling of CpG island methylation status
(Cheng et al. 2006). Briefly, it first utilizes two-run multiplexed PCR to amplify multiple
target DNA sequences, followed by multiplex ligation reactions with two discriminating
and one common ligation primers. The discriminating primers contain 5’ fluorescent label
(Cy5/Cy3) and 3’ discriminating nucleotides corresponding to methylation or
unmethylation CpG sites. The common ligation primers contain distinct zip-code
sequences, which are designed with similar thermodynamic properties and high
specificity. These unique zip-code sequences allow for the hybridization to be performed
at the same temperature under more stringent conditions to reduce the non-specific
interaction (Gerry et al. 1999; Fan et al. 2000; Favis et al.2000). Finally, the ligation
products are analyzed using the zip-code universal microarray to determine the
methylation status at each target CpG site. Using this assay, 75 CpG sites from 15 tumor
suppressor genes are evaluated simultaneously. Furthermore, as the zip-code microarray
can be easily expanded, additional CpG sites and genes can be added to the panel.
In the second method (Bibikova et al. 2006), the investigators from Illumina
apply their GoldenGate genotyping system to methylation analysis (Fan et al. 2000). This
approach first utilizes ligation on a bisulfite-converted template to produce both
methylated and unmethylated alleles, followed by multiplexed PCR to amplify the ligated
sequences containing the target CpG site. The methylation status at each CpG site is
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analyzed using a zip-code microarray as well. In this assay, a gap of 1-20 bases was
designed between one pair of ligation primers to help sequence selection and to improve
the specificity of primer-template annealing. The elongation with polymerase and ligation
with ligase takes place simultaneously. Another advantage of this assay is the
improvement of multiplex PCR efficiency. As the pairs of ligation primers have identical
universal sequences, the multiplex PCR can be performed with only one pair of primers
having universal sequences. This is different from the PCR/Ligation assay, where a
number of primers are used in one reaction for amplification and the efficiency of each
amplification varies greatly. In PCR amplification based assays, the PCR products are
critical to the microarray analysis. Compared with direct hybridization based microarray,
ligation based microarray improves specificity, allowing for methylation analysis of
cancer cell lines or tumor tissues that contain a high abundance of tumor cells.
2.2.3 Bisulfite Based Genome-Wide Microarray
Due to DNA degradation in bisulfite treatment, PCR products have not been
used for genome-wide methylation profiling. Recently, a novel whole-genome
methylation profiling method, called BiMP (Bisulfite Methylation Profiling), was
developed to amplify 100ng of bisulfite-converted DNA (Reinders et al. 2008). Unlike
the standard whole-genome amplification method, BiMP reduces the length of the
random primers from 6mers to 4mers to favor the priming of smaller DNA fragments,
and to reduce the amplification bias for bisulfite-converted DNA. All of the random
primers are labeled with the same sequences, which can be used as universal primers for
the PCR amplification. As a result, improved uniformity of amplification of
whole-genome was achieved. Finally, the PCR products are hybridized with standard
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high-density oligo tiling microarray from Affymetrix. In the future, the detection can be
performed on custom arrays with methylation-specific oligos as the design in MSO
microarray. This new strategy should improve the sensitivity and specificity of BiMP.
2.3 Restriction Enzyme Based Method
Recently, many variations of restriction enzyme based methods were developed
for methylation analysis, in particular for genome-wide methylation profiling (Tompa et
al. 2002; Lippman et al. 2004; Lippman et al. 2005; Hatada et al. 2006 ; Khulan et al.
2006; Schumacher et al. 2006; Yuan et al. 2006 ; Shann et al. 2008). Via the cleavage of
either methylation-sensitive or methylation-insensitive restriction endonucleases, either
methylated and unmethylated alleles can be enriched for large-scale analysis. All of the
restriction enzyme based microarray can be assorted into three categories: digested and
non-digested samples; digesting with methylation-sensitive and methylation-insensitive
enzymes; digesting mutant and wild-type samples (Zilberman and Henikoff et al. 2007).
2.3.1 Digestion and Non-Digestion
As the most common approach, two portions of the same DNA sample are
treated with or without restriction enzyme, followed by comparison of these two groups
using microarray. Lippman et al. used the restriction enzyme McrBC, which prefers
methylation DNA as a substrate, to selectively exclude the methylated fractions in whole
sequence (Lippman et al. 2004; Lippman et al. 2005; Ordway et al. 2006). Then the
enzyme treated DNA and non-treated DNA are gel-purified to keep the fragments bigger
than 1kb, which are labeled with Cy5/Cy3, respectively. Labeled two portions are mixed
together, and detected on one tiling microarray, which contains contiguous stretches of
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chromosomes without bias to evaluate the methylation status of whole sequence
simultaneously at high resolution. If the signal intensity from a non-treated sequence is
higher than the treated sequence, this sequence targeted region is methylated. All
methylated sequences are excluded by McrBC, whereas the non-treated sample retains all
methylated DNA. In contrast, the unmethylated sequences can be excluded by
TspRI-HpaII-ExoIII microarray assay, where DNA is digested with TspRI and HpaII,
followed with ExoIII (Shann et al. 2008). Correspondingly, another portion of DNA is not
treated with HpaII as control. These two portions of fragments are labeled with different
dyes after the digestion for the microarray detection.
To improve the sensitivity, Yuan et al. used Affymetrix SNP chip combing with
methylation-sensitive restriction enzyme HpaII for methylation profiling (Yuan et al.
2006). In the Affymetrix technology, PCR amplification with ligation adaptors reduces
the required amount of DNA sample. In the assay, the sequences without methylation are
cleaved with HpaII, and can not be amplified by PCR and can not be observed by the
final array detection. The parallel DNA sample with HpaII digestion can serve as a
control. With this improvement, only 600ng genomic DNA is required on 50K chips,
instead more than 10μg needed for non-PCR amplification approach (Lippman et al.
2005). Again, with PCR amplification, the DNA derived from formalin-fixed, and
paraffin-fixed breast cancer tissue has been interrogated (Melnikov et al. 2008). This
assay avoids degradation of the DNA sequence in bisulfite treatment for a limited clinical
sample.
2.3.2 Methylation-Sensitive and Methylation-Insensitive Enzymes Digestion
As we described in Chapter 1, the methylation-sensitive restriction enzyme
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HpaII, and methylation-insensitive isoschizomer MspI are most two common enzymes
used in methylation analysis. Based on the digestion of these two enzymes, Khulan et al.
developed a powerful method called HELP (HpaII tiny fragment Enrichment by
Ligation-mediated PCR) for methylation profiling (Khulan et al. 2006). The HELP assay
is based on the comparison of DNA samples digested by HpaII and MspI using
microarray. Two portions of the DNA sample with high molecular weight are digested
with HpaII and MspI, and ligated with an oligonucleotide pair on the site cleaved by
restriction enzyme, respectively. Primed by these ligated oligonucleotides, the digested
DNA can be amplified and labeled with different fluorescent dyes. Finally, the HpaII and
MspI representations are hybridized on high density microarray. The ratio between these
two representations can reveal the methylation status. The MspI representation provides a
robust internal control to compare with HpaII representation, and detects the copy
number of cancer cells, in which amplification and deletions are common. Furthermore,
the HELP assay can be used on the other commercial microarray slides with the suitable
combination of restriction enzyme isoschizomers for high-throughput genome-wide
methylation profiling. Since more than 80% of all CpG islands are not related to
regulation of gene expression, Hatada et al. developed more specific Microarray-based
Integrated Analysis of Methylation by Isoschizomers (MIAMI) for promoter methylation
profiling (Hatada et al. 2006). In this assay, lung cancer cell lines and normal lung cells
are subjected to HpaII digestion, adaptor-ligation/PCR, followed by MspI digestion, and
2nd PCR and labeling. With microarray detection, the HpaII resistance was calculated for
both the cancer cell and normal cell lines. Moreover, another portion of lung cancer cell
and normal lung cells are subjected to MspI digestion, followed by using the same
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procedure as the HpaII digestion. With the microarray detection, the MspI resistance was
calculated as well. After analysis of HpaII resistance and MspI resistance, threshold
criteria was made to judge the methylation status of the microarray spots to the
corresponding sequence in the promoter. Under this criteria, new epigenetic mutations
can be detected in cancer cells.
Instead of using single enzyme for DNA digestion, methylation-sensitive
restriction enzyme cocktails were used to improve the resolution of detection
(Schumacher et al. 2006). To enrich the unmethylated fraction, several combinations of
methylation-sensitive enzymes, HpaII, Hin6I, AciI and HpyCh4IV were used to digest the
genomic DNA, interrogating more than 41% CpG sites, followed by adaptor-ligation.
McrBC was used to remove all of the methylated Cytosine in CpG sites. The cleaved
methylated sequences can not be amplified or labeled. To enrich the methylated fraction,
methylation-insensitive enzyme TasI or Csp6I was used for the digestion. After the
adaptor-ligation, methylation-sensitive cocktails were used to remove the unmethylated
CpG sites. Both of these two fractions were detected by microarray. This assay provides a
useful tool for both hypomethylation and hypermethylation detection.
2.3.3 Digestion of Mutant and Wild-Type Samples
Comparison between the digestions of mutant and wild-type samples is the most
common method in microarray. Yan et al. digested the tissue and wild-type control
samples with MseI, followed by adaptor-ligation (Yan et al. 2001). Thereafter, the ligation
DNA was digested with methylation-sensitive enzymes BstUI and HpaII. The tissue and
wild-type control samples were labeled with different fluorescent dyes after the PCR
amplification, and cohybridized on microarray, which is derived from a CpG island
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library. Since the MseI fragments are not abundant in CpG islands, it was found that both
non-CpG and CpG sequences were amplified. To improve the sensitivity and reduce the
amplification of non-CpG sequences, a new adaptor-ligation method was used for
methylation-specific amplification (Hatada et al. 2002). In this approach, the cancer cell
lines and normal control samples were digested with methylation-sensitive enzyme SmaI
firstly, followed by methylation-insensitive enzyme XmaI cleavage. Then, the
adaptor-ligation takes place on XmaI cleaved sites. Hence, only methylated sequences
could be amplified and detected by microarray. In addition, higher percentages of DNA
fragments derived from hypermethylated loci were selected from the CpG island library.
For the sample containing large amounts of DNA, Tompa et al. used MspI to
digest the mutant sample and wild-type control, followed by size fraction to get
fragments less than 2.5kb. The fractions of mutant and wild-type control without PCR
amplification were labeled with different dyes for the direct microarray detection (Tompa
et al. 2002). Recently, two other methylation-sensitive enzymes, HpyCH4IV and HpaII,
were used for methylation profiling based on the same principle (Tran et al. 2005).
2.4 Immunology Based Method
The restriction enzyme based microarray requires high-molecular-weight DNA
and is limited by the distribution of the restriction sites of the chosen endonucleases. For
example, the HpaII sites only comprise 8% of the CpG sites in the human genome. To
overcome these limitations, 5-Methylcytosine antibody or 5-Methylcytosine binding
domain (MBD), immunoprecipitation and affinity chromatography followed by tiling
microarray detection have been used for methylation profiling (Weber et al. 2005; Keshet
et al. 2006; Zhang et al. 2006; Hayashi et al. 2007; Penterman et al. 2007; Zilberman et al.
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2007). In the tiling microarray, nucleic acid probes can either overlap, lay end-to-end, or
be spaced in the target genomic region. There can be classified into two major classes of
tiling microarray on the basis of the fabrication of tiling microarray: oligonucleotide
tiling microarray; PCR products or bacterial artificial chromosome (BAC) microarray. In
the oligonucleotide tiling microarray, relatively short oligonucleotide probes (25-85bp)
can be directly synthesized on the surface of the solid support by photolithography
(Fodor et al. 1991; Pease et al. 1994), ink-jet device (Hughes et al. 2001; Wolber et al.
2006), or programmable mirrors techniques (Singh-Gasson et al. 1999). This high-density
microarray can provide 6.6 million spots in <2cm2. Alternatively, the synthesized
oligonucleotide probes can be printed in low-density on the solid support by mechanical
printer. In this low-density printing array, 10,000-40,000 spots can be spotted in single
chip (1 inch X 3 inch). In the PCR products or BAC tiling microarray, the PCR products
or BAC clones are printed on microarray array.
2.4.1 PCR Products and BAC Based Tiling Microarray
BAC tiling microarray has been used in comparative genomic hybridization
(CGH) for identification of chromosomal imbalances and variation in DNA copy-number
(Albertson et al. 2000; Snijders et al. 2001; Ishkanian et al. 2004). This quantitative and
high-throughput technique is now attracting wide-spread interest, especially among
methylation researchers. Weber et al. developed methylated DNA immunoprecipitation
(MeDIP) combined with BAC tiling microarray for whole-genome as well as
promoter-specific methylation analysis, where methylated DNA was captured by
5-methylcytosine antibody, and hybridized to microarray to achieve a more unbiased
analysis (Weber et al. 2005). In this assay, sheared genomic DNA between 300-1,000 bp
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was incubated with the antibody against 5-methylcytosine. Then the captured methylated
DNA fragments were isolated by immunoprecipitation using Dynabeads with antibody.
The methylated DNA and input DNA (total DNA) were labeled with different fluorescent
dyes for microarray hybridization. In the data analysis, the signal ratio of methylated
DNA and input DNA could reveal the methylation status. In the BAC microarray
fabrication, 32,433 BAC clones with 80Kb resolution in genome-wide, and 12,192 BAC
clones derived from CpG island library were prepared for the slides printing. In this assay,
the resolution and coverage of CpG sites are mainly determined on the microarray BAC
fragments distribution, unlike the restriction sites of endonuclease.
As an alternative, PCR products can be used for tiling microarray printing (Rinn
et al. 2003; Odom et al. 2004). Combined with MeDIP, they were also used in
genome-wide methylation analysis (Keshet et al. 2006). In the microarray fabrication,
13,000 individual PCR amplifications derived from promoters were printed on array
slides one by one. As in the case of the BAC tiling array, the input DNA and methylated
DNA from immunoprecipitation were labeled with different dyes for microarray
detection. After stringent analysis, the MeDIP based method can recognize the
methylation region with the CpG density of larger than 2% and is ideally suitable for
CpG island methylation detection. One has used this assay for colon cancer cell lines
Caco-2 methylation analysis and a set of 135 gene promoters were found methylated, 127
of which were contained in CpG islands.
The problem with BAC and PCR tiling microarrays is that they are labor
intensive. For example, in the tiling microarray fabrication for human chromosome 22,
more than 20 000 PCR reactions must be designed to achieve a 1-Kb resolution (Rinn et
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al. 2003). If the entire human genome tiling array was made in this way, more than two
million PCR reactions are required (Royce et al. 2005). Hence, researchers generally
adopted oligonucleotide based tiling microarray for methylation research.
2.4.2 Oligonucleotide Based Tiling Microarray
Tiling microarray can be classified into two groups on the basis of the length of
oligonucleotides:

short

oligonucleotides

(25-mer)

from

Affymetrix

and

long

oligonucleotides (45-mer to 85-mer) from NimbleGen and Agilent. In the Affymetrix
platform, each perfect-match oligonucleotide probe, alone with a single mismatch probe
in the central base (position 13 of 25), is synthesized on glass slides using the
photolithographic technology. The mismatch probe will provide a measurement of
nonspecific target DNA binding to the perfect match. These short oligonucleotides
improve the specificity, but suffer from decreased sensitivity, probe variability, and noise.
To avoid these drawbacks, several stringent statistical methods have been developed for
the data analysis, including the two-state hidden Markov model based on probe-level
t-statistics (Carroll et al. 2005; Ji and Wong et al. 2005; Li et al. 2005), non-parametric
Wilcoxon rank sum test (Cawley et al. 2004; Bernstein et al. 2005), and non-parametric
Kolmogorov-Smirnov test (Zhang et al. 2006). In the long oligonucleotide microarray
platform, only perfect match probes to genomic sequence are built on the microarray by
photolithographic technology (NimbleGen), or ink-jet device (Agilent). These longer
probes result in reducing the microarray density, but provide a better balance of
specificity, sensitivity, and non-specific binding than the Affymetrix shorter platform
(Kreil et al. 2006). Furthermore, the data derived from these long oligonucleotide
platforms requires less statistical analysis.
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With the Affymetrix platform, Zhang et al. reported the first comprehensive,
high-resolution DNA methylation mapping of the Arabidopsis thaliana genome (Zhang et
al. 2006). This whole genome tiling array contains ~6.4 million of 25-mer
oligonucleotide probes for each 35 bp genomic region, which covers ~97% of one strand
from five chromosomes (~120Mb). In the sample preparation, methylated DNA and
unmethylated DNA were fractionated by MeDIP using 5-methylcytosine antibody, or by
affinity chromatography using 5-Methylcytosine binding domain (MBD). Then, the
fractions were subject to whole genome amplification and labeling with different dyes for
microarray detection. The methylation patterns revealed in this method are consistent
with previously individual loci analysis, and provide an invaluable reference for research
in the individual loci from the genome in the future (Schöb and Grossniklaus 2006).
Hiroshi et al. developed the tiling array covering ~30 Mb of human genome (1%), using
Affymetrix platform (Hayashi et al. 2007). Combined with MeDIP, this unbiased,
scalable, and detailed mapping technique was used for human colorectal cancer cell
methylaiton profiling. As the tiling microarray for the whole human genome is being
developed by Affymetrix, we can expect this will lead to a significant impact on human
genome-wide methylation research.
The group led by Henikoff successfully adopted the NimbleGen microarray from
gene expression to plant methylation research (Mito et al. 2005; Mito et al. 2007;
Penterman et al. 2007; Zilberman et al. 2007). Due to the large amount of DNA isolated
from plant, the fractions of input and methylated DNA derived from MeDIP were labeled
with different dyes and cohybridized on the tiling array without PCR. Using raw DNA
can result in good results without the complicated statistical manipulation. Moreover, the
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custom tiling arrays built by NimbleGen allows for the more flexible experimental
design.
Again, in human methylation research, this flexible tiling array system has
shown great power recently. Weber et al. migrated from BAC tiling microarray to
NimbleGen oligonucleotide microarray to study the impact of methylation on gene
expression in human genome (Weber et al. 2007). In this study, ~16,000 high-confidence
promoters in human primary somatic and germline cells and each with 15
oligonucleotides were analyzed using MeDIP combined with tiling microarray. By
mapping DNA methylation within the major human promoters, researchers that show the
CpG island promoters with high ratio of CpG sites are mostly unmethylated, whereas the
CpG-poor promoters are mostly hypermethylated in somatic cells. This comprehensive
promoter methylation map provides intriguing insights into genome evolution, cellular
differentiation, and their relation to tumorigenesis (Zilberman 2007). Later, Rauch et al.
described another application of NimbleGen and Agilent platforms to high-resolution
profiling of hypermethylation and hypomethylation in lung cancer (Rauch et al. 2007;
Rauch et al. 2008). Briefly, methylated fractions were enriched by MBD proteins from
lung squamous cell carcinomas and normal tissues extracted DNA, respectively. The
fractions were cleaved by MseI digestion, followed by adaptor-ligation. After PCR
amplification, these two fractions were labeled with different dyes for microarray
cohybridization.
2.5 Conclusion
In this chapter, major microarray platforms can be grouped into three groups:
bisulfite conversion, restriction enzyme, and immunology. Due to the significant losses
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and cleavage of template DNA in bisulfite conversion, bisulfite based microarray is
appropriate for the analysis for individual loci, specific genes, or specific sites. On the
other hand, the conversion creates a nearly C-less sequence of mostly 3-base-DNA
having predominantly A, G, and T. The reduction in sequence complexity facilitates the
non-specific binding between bisulfite-treated template and probe (primer). It is difficult
to maintain the specificity and sensitivity in genome-wide analysis. As alternatives,
restriction enzyme and immunology based methods are capable for genome-wide
methylation

analysis,

combined

with

high-resolution

tiling

microarray.

The

high-molecular-weight requirement and a limited number of recognizing sites for chosen
endonucleases are the two drawbacks of restriction enzymes based microarray. To avoid
these two limitations, 5-methylcytosine and MBD proteins based methods are developed
for methylation analysis in genome-wide and promoters. All of the microarray platforms
for methylation research are very young technologies at present. Undoubtedly, with
development and refinement, these platforms hold great promises to unlock the
relationship between cancer and methylation, as well as to provide valuable prognostic
and diagnostic tools.
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CHAPTER III

MICROARRAY FABRICATION

This chapter discusses how we fabricate home-made microarray. The
commercial oligonucleotide microarrays manufactured by Affymetrix, Illumina,
NimbleGen, and Agilent have facilitated research in gene expression, mutation detection,
and genotyping. However, the cost and complexity of these platforms make them less
adaptable by many researchers, who prefer printed microarray, which is more flexible in
design and content, and potential cost saving over commercial arrays. Due to the
technical variability in printed microarray, significant differences exist in microarray
fabrication and post manipulation. In order to produce high quality microarray data, the
following parameters have been extensively studied: solid supports selection,
oligonucleotide modification, printing procedure optimization, fluorescent dyes selection,
hybridization procedure optimization, and highly discriminative zip-code sequences
selection.
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3.1 Solid Support Selection and Spotting Optimization
3.1.1 Solid Support Selection
To develop reliable oligonucleotide microarrays, the immobilization of probes on solid
support is one of the most essential and important subjects. A number of noncovalent and
covalent methods can be used to immobilize oligonucleotides on solid support, which, in
general, has two major forms: nylon membrane and glass slide. Due to the high
fluorescent background, chemiluminescence is the most common detection method for
nylon membrane. As the two-color or four-color fluorescent detection system is broadly
used in microarray, glass slides with different functional surfaces are more suitable for
fluorescence-based microarray. Glass as a support material has many advantages over
other support: its non-porous structure requires low reaction volumes; it is durable to
chemicals and high temperatures; low-background is very well suited for the
fluorescence-based detection. The glass slides are commonly modified with several
functional groups such as carboxyl (Lindroos et al. 2001), thiol (Rogers et al. 1999),
poly-L-lysine (Schena et al. 1995), amine (Pack et al. 2007), aldehyde (Dawson et al.
2005), and epoxy (Wrobel et al. 2003). In the noncovalent immobilization, the DNA can
be fixed on the glass surface by acid-base interaction, hydrogen bonding, and electrostatic
interactions. In contrast, the terminal covalent attachment allows the entire
oligonucleotide to be available for hybridization and to withstand the high temperature
and salt concentration often required during the stringent washing conditions in
subsequent steps of microarray processing. Hence, to yield reproducible results, covalent
immobilization was used in our platform development. Direct covalent coupling is most
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commonly achieved using amino-terminated oligonucleotides and either aldehyde or
epoxy modification glass. For these reasons, this study focused on the immobilization of
amino-terminated oligonucleotides to aldehyde and epoxy modified glass slides.
First, epoxy or aldehyde slides (CEL Associates, Pearland, TX) were printed,
blocked, and washed under the same conditions. Then, mini-sequencing products were
hybridized with the immobilized oligonucleotides under the same condition. In Fig. 3, it
is seen that the background of epoxy is much stronger than aldehyde slides, although
there was no significant difference between the strength of signals. The reason for the
high background is the different property of these two modifications. The aldehyde
surface is hydrophilic, whereas the epoxy surface is hydrophobic. The fluorescent dyes,
modified from ddNTP or dNTP, mostly are hydrophobic. After the hybridization, it is
difficult to clean the surface. Hence, we preferred aldehyde modification to epoxy
modification. The aldehyde slides made by different companies such as Erie Scientific,
CEL, Corning, and TeleChem were tested. Finally, CEL aldehyde slides were chosen in
this thesis work for their high binding capacity, low background, and cost-saving
features.
3.1.2 Optimization of Spotting, Immobilization, and Wash Conditions
Several

recent

studies

that

investigated

immobilization

of

short

NH2–oligonucleotides on aldehyde–glass employed a number of vastly different
protocols for spotting and processing of microarray slides (Lindroos et al. 2001; Booth et
al. 2003; Al-Khaldi et al. 2004; Hou et al. 2004; Deyong 2005). In these protocols,
different immobilized solutions are used, such as DMSO, SSC, alkaline phosphate,
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A

B

Fig. 3 Modified glass selection. (A)Aldehyde modification glass support and (B) epoxy
modification glass support were immobilized, blocked, and washed under the same
condition and hybridized with the same SBE products.
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sodium carbonate, and some commercial solutions. Furthermore, different temperature
(from room temperature to 75 oC), humidity (from <30% to 100%), and time (from 15min
to 48h) were used in the printing. These examples demonstrate a clear need to investigate
a number of variables in oligonucleotide microarray fabrication and processing
procedures, as it is impossible to compare the results of similar experiments conducted
under such vastly different conditions.
Laura R. Kuck and co-worker tested and compared different types of spotting buffer and
chose 3XSSC/0.05% SDS/0.001% Chaps as the spotting buffer, which was also used in
our studies (Dawson et al. 2005). After printing, glass slides were kept for 24 hours at
room temperature in the hood (humidity <30%), a sealed container with saturated NaCl
solution, and a sealed container with water respectively. All of these slides were blocked,
washed, and hybridized under the same condition. We found that under the low humidity
the printing spots were not uniform. And the spots formed ‘donut’ circles without signals
in the center. When we increased the humidity using saturated NaCl solution and pure
water, the donut disappeared gradually (Fig. 4 A). Hence, saturated humidity must be
kept in the post-spotting process to improve the reaction between oligonucleotides and
the modified surface. To optimize the post-spotting temperature, we studied the slide
performance at room temperature, 37oC, and 55 oC for 12 hours, and 80 oC for 1 hour,
respectively. We didn’t find any significant difference except for the higher temperature
inducing high fluorescent backgrounds. The reason for this could be that after the
incubation at high temperature, the salt and oligonucleotides changed the surface of spot
area, which was displayed as a fluorescent signal under high sensitivity scanning. We did
the blank test at room temperature and 80 oC, respectively. The later condition showed
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Fig. 4 Post-printing humidity and temperature selection. (A) Humidity Test: less than
30% humidity at room temperature (left); the humidity of saturated NaCl solution at
room temperature (middle); the humidity of water at room temperature (right). (B) Blank
Test: printed slides were left at room temperature for 12 h (left); printed slides were
baked at 80 oC for 1 h (right).
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high background and produce the false-positive signal in the test (Fig. 4 B). Hence, we
performed the post-spotting at room temperature for 12-48 hours. In the blocking and
washing step, the excess of aldehyde-reactive groups were deactivated by keeping the
slides for 25 min at room temperature in Pronto™ pre-soak solution (Corning, NY),
followed by washing with buffer I and II of Pronto™ Universal Microarray Validation kit
(Corning, NY).
3.2 Oligonucleotide Modification Optimization
In this study, we attached an amino group to all of the oligonucleotides. The 3’
terminal or 5’ terminal could be chosen as modification site. To reduce steric interference
from the solid surface that affects the hybridization between probes and targets, the
immobilized oligonucleotides must be lifted up from the surface. When the
oligonucleotides were synthesized, C3, C5, C6 or C12 was linked to amino to increase
the space (Gerry et al. 1999; Gitan et al. 2002; Moreno et al.2006). C6 and C12 linkers
are the most common in the microarray. In order to increase the space, a spacer consisting
of a poly thymine chain up to 15 bases in length was added in the synthesis (Lindroos et
al. 2003; Hultin et al. 2005; Pourmand et al. 2007). In our study, C3, C6, C12 linkers and
15T spacer were tested. We chose one oligonucleotide, which was synthesized with
different carbon linkers to hybridize with the same PCR product. The strongest signal
was C3 amino linker, and the weakest signal was C12 amino linker (Fig. 5). Five
different oligonucleotides were tested by this way, and the same result was seen. The
reason for this gradual change is probably the hydrophobic property of C12 and the
hydrophilic property of aldehyde surface. Another reason is the solubility of C12 linker in
the spotting buffer. The C12 linked to amino makes it difficult to dissolve amino in the
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Fig. 5 Carbon linker selection. C3, C6, and C12 linkers comparison: the same
oligonucleotide with different carbon linkers were synthesized in the amino modification.
Each oligonucleotide was printed 10 times on the same aldehyde slide, then hybridized
with the same PCR product.
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spotting buffer. As a result, the amino and aldehyde reactive group on the slides were not
fully contacted. This decreased the immobilized efficiency of an amino modified
oligonucleotide on aldehyde slides.
15T spacer was also tested with 6 oligonucleotides, three of which included 15T
spacer and three of did not. No significant difference was found by us. Again, in our
SBE-TAGs and CHZMA platforms, the hybridization efficiency was not influenced by
15T spacers. Hence, in the universal zip-code microarray, oligonucleotides were
synthesized with a 3C linker and without a 15T spacer.
3.3 Fluorescent Dyes Selection
As an alternative to radioisotopic labeling, fluorescent labeling enables the
signal detection with a high resolution in microarray. On the other hand, the combination
of multiple fluorescent dyes used in a single reaction became available for the sequence
variation changes detection such as SNP and methylation. Two kinds of labeling, direct
and indirect, are used in the microarray system. In the direct labeling, fluorescence
modified oligonucleotides, ddNTPs, and dNTPs can be incorporated into DNA strands by
enzymatic reactions, such as PCR, ligation, SBE (Gitan et al. 2002; Lindroos et al. 2002;
Bibikova et al. 2006; Cheng et al. 2006). In the indirect labeling, biotin or aminoallyl
modified oligonucleotides, ddNTPs, and dNTPs can be incorporated into DNA strands by
enzymatic reaction, followed by conjugating with fluorescent dyes using chemical or
enzymatic reactions (Hoen et al. 2003; Zhang et al. 2006). Generally, four-color
fluorescent labeling is used in the SNP and mutation detection and two-color and
single-color fluorescent labeling are used in the methylation detection.
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Due to the fact that different dyes have considerable differences in their
photostabilities and fluorescence efficiencies, fluorescein, Texas-red, Cy3, and Cy5 were
tested by us on a laser-induced fluorescence system, Typhoon 9410, which has four lasers
including: 457nm, 488nm, 532nm, and 632nm. All of these four dyes are equally
separated on the major fluorescent area from 400nm to 750nm with minimal overlap (Fig.
6). Using single-base extension, we tested several combinations of these four dyes for
methylation analysis. The combinations are listed in Table I. After the comparison,
Combination 3 is determined to be the best candidate for our methylation analysis. As an
addition, combination 5 is another good candidate except for the low fluorescent
efficiency of fluorescein.
The problems of Combination 1 are that fluorescein has low excitation efficiency
(83000), and Texas-red does not have a matched laser for excitation. In Typhoon 9410,
Texas-red is excited by a 532nm laser, which is far from the optimum absorption (583nm)
of Texas-red. With the same problem of Texas-Red, Combination 4 is not a good
candidate either.
We next compared Combination 2 with Combination 3, where unmethylated
PCR product was used as template for SBE in the presence of Cy5 ddATP and Cy3
ddGTP (Combination 2) or Cy5 ddGTP and Cy3 ddATP (Combination 3). In the SBE
reaction, only Cy5 ddATP is incorporated into extended products with the unmethylated
template in the case of Combination 2. But as shown in Fig. 7, both Cy3 and Cy5
channels show signals after we scanned array slide with 583nm and 632nm lasers,
respectively. The reason for this is that Cy5 ddATP can be excited by both 583nm and
632nm lasers, but the signal from 583nm laser is corresponding to the methylation
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Fig. 6 Fluorescence spectra of selected dyes. Absorption and emission of fluorescence
Spectra: broken line is for the absorption peak and solid line is for the emission peak;
Green, red, black, and blue are corresponding to fluorescein, Texas-red, Cy3, and Cy5,
respectively.
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Table I. Different combinations of ddATP and ddGTP were studied in the
SBE reaction.

Combination 1

Combination 2

Combination 3

Combination 4

Combination 5

ddATP

Texas-red

Cy5

Cy3

Texas-red

Cy5

ddGTP

Fluorescein

Cy3

Cy5

Cy5

Fluorescein
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Fig. 7 ddATP and ddGTP fluorescent labeling selection. Combination 2 and 3 were
used for the SBE reaction using unmethylated PCR product as the template. After
hybridization, microarray slides were scanned in Cy5 (632nm) and Cy3 (583nm)
channels, respectively.
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detection. This can lead to false-positives for the methylation evaluation. Hence,
Combination 2 can not be selected for the SBE reaction. In contrast, using Combination 3
for the SBE reaction with unmethylated template, only Cy3 channel has signal. No signal
was found in Cy5 channel because Cy3 ddATP can not be excited by the 632nm laser.
3.4 Hybridization Optimization
Hybridization between single-stranded probes and target molecules occur
through hydrogen bonds formation between the bases of complementary nucleic acid
sequences. Sequence composition, target and probe length, hybridization temperature,
secondary structure, degree of homology, salt concentration, pH, and a number of other
factors influence the hybridization efficiency and the strength of the double helix
structure. LifterSlip system (Erie scientific, NH) and ProPlate™ Multi-Array Slide
System (Grace Bio labs, OR) were compared for the hybridization. The LifterSlip system
uses 15~23μL hybridization volume and 3 areas in a slide. The ProPlate™ Multi-Array
Slide System uses 40~200μL hybridization volume and 16 areas in a slide. Under the
same condition, High background was detected in the LifterSlip system (Fig. 8 A). After
8~12 hours hybridization, unknown substances bond to on the surface of the array slide.
Hence, we used ProPlate™ Multi-Array Slide System for the hybridization of our
home-made microarray.
We next studied the hybridization buffers. SSC series buffer, SlideHyb buffer
(Ambion, TX), Pronto™ short oligo hybridization buffer (Corning, NY), and PCR buffer
(GE healthcare, NJ) were tested. High background and poor signal were detected in the
first two hybridization buffers. Low background and high discrimination were seen by

53

A

B

Fig. 8 Microarray hybridization condition optimization. (A)LifterSlip hybridization
system and ProPlate™ Multi-Array Slide System comparison: the left is LifterSlip
system with higher background and the right is ProPlate™ Multi-Array Slide System. (B)
Coring hybridization buffer (right) and GE healthcare PCR buffer (left) comparison.
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using Coring buffer. Low background and strong signal were detected by using PCR
buffer. As seen from Fig. 8 B, the signal from the PCR buffer is stronger than that from
Coring buffer, but with more crosslink and nonspecific binding between different
sequences. Hence we selected Pronto™ short oligo hybridization buffer as our
hybridization buffer.
In the universal zip-code microarray, all of the zip-code sequences immobilized
on the slides are 23 bases, with the melting point of 62~66oC. In order to obtain the
optimal hybridization temperature to achieve the sufficient specificity, we tested the
hybridization from 38 oC to 63 oC. Finally, 54 oC was selected for this group of zip-code
probes.
3.5 Highly Discriminative Zip-Code Sequences Selection
A highly discriminative and specific sequence is the critical factor for the
microarray. To design the zip-code sequences, all possible 20~24 mers were subject to a
computational screen to generate a set of sequences with similar GC content,
thermodynamic properties, and minimal cross-hybridization (Gerry et al. 1999;
Shoemaker et al. 1996; Giaever et al. 1999; Winzeler et al. 1999; Favis et al. 2000).
However, individual oligonucleotides still differ in their performance. It is not possible
currently to predict all of the performance parameters of particular probes in microarray
experiments simply by theoretical calculations (Pozhitkov et al. 2006). In our low density
tag microarray, we must ensure that the methylation status of each gene or each specific
region. As a result, stronger and more specific interactions between the zip-code
sequences and complement zip-code sequences are required.
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The strategy to select highly discriminative sequences is illustrated in Fig. 9. In
the selection, all of the candidate zip-code oligonucleotides with 3C amino linker at 3’
terminal (MWG-Biotech Inc., AL) were printed on aldehyde modified microarray slides
(CEL, TX) with XactII Compact Microarrayer (LabNEXT Inc., IL). In the SBE reaction,
a chemically synthesized single-strand oligonucleotide was used as the template for all of
the candidate sequences. All SBE primers are designed with the identical gene-specific
sequence for the chemically synthesized template and different candidate zip-code
sequences. All of the SBE for different sequences were performed in individual tubes and
the hybridization took place in a different subarray area. Typically, the selection criteria is
that the signal from a perfect match spot is at least 10 folds higher than the signal from a
mismatch spot. We were able to select 32 discriminative and specific zip-code sequences
from 70 candidates for the fabrication of a universal tag microarray. The sequences of 32
zip-code are listed in the Appendices.
3.6 Conclusion
In this chapter, we describe the study of the fabrication of our home-made
microarray. It generates the standard procedure for our future research. First, the highly
discriminative tag probes (MWG-Biotech Inc., AL) are synthesized with 3C amino
modification at 3’ terminal without poly-T spacer. Second, the probes are dissolved in the
printing buffer of 3XSSC/0.05% SDS/0.001% Chaps, and printed on aldehyde modified
microarray slides (CEL, TX) with XactII Compact Microarrayer (LabNEXT Inc., IL).
After spotting, the printed slides were incubated in a container with the saturated
humidity of water at room temperature for 12-48 h. Then, the printed slides are placed in
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Fig. 9 Schematic outline for highly discriminative tag selection. A chemically
synthesized single-strand oligonucleotide is used as the template for SBE reaction of tag
selection. The SBE primers are designed with the identical gene-specific sequence
(highlighted in blue) and different tag sequences including: tag 1, tag 2, and tag 3. In the
SBE, all tag primers are added to different tubes for the cyclic reaction separately.
Correspondingly, the hybridization is performed in different subarray area for each tag
primer separately. For example, if the SBE primer with tag 1 (highlighted in red) is
detected at the position of anti-tag 1 on the microarray, tag 1 is thus highly discriminative.
Contrarily, in the tag 2 selection, if two positions of anti-tag 2 and anti-tag 3 are all
detected with positive signal, then tag 2 has low discrimination.
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the desiccator for future use. Before the hybridization, the excess of aldehyde-reactive
groups are deactivated by placing the slides in Pronto™ pre-soak solution (Corning, NY)
for 25 min at room temperature, followed by washing with buffer I and II in Pronto™
Universal Microarray Validation kit (Corning, NY). Third, in the two-color microarray
system, Cy5 and Cy3 can be used for the labeling of methylation and unmethylation
signal, respectively. Fourth, the hybridization of microarray slides can be processed on
ProPlate™ Multi-Array Slide System (Grace Bio labs, OR) using Pronto™ short oligo
hybridization buffer (Corning, NY) at 54 oC for 3-12 h. Fifth, the array slides are rinsed
with SSC buffer and ddH2O, and scanned in a laser-induced fluorescence system,
Typhoon 9410. And the data is analyzed by ImageQuant or ArrayVision.
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CHAPTER IV

MULTIPLEX METHYLATION ANALYSIS BY SBE-TAGS
MICROARRAY

4.1 Abstract
DNA methylation analysis plays a pivotal role in unlocking association of
epigenetic events with cancer. However, simultaneous evaluation of the methylation
status of multiple genes is still a technical challenge. In this work, we describe the use of
SBE-TAGs microarray for the simultaneous determination of methylation status of
multiple genes. 10 CpG sites of 9 tumor suppressor genes (MGMT, GATA4, HLTF,
SOCS1, p16, RASSF2, CHFR, TPEF, and Reprimo) were selected for this study. We
found that SBE-TAGs microarray performed quite well in multiplex methylation analysis
if a standard calibration curve method was used. In addition, SBE-TAGs is robust and
reproducible. Hence, this work suggests that SBE-TAGs microarray can be a
high-throughput method for multiplex methylation analysis.
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4.2 Introduction
DNA methylation is a key event regulating gene expression. In vertebrates, the
majority of 5'-methylcytosine occur at CpG sites within the promoter, often resulting in
transcriptional inactivation of genes (Huang et al. 1999; Jones and Laird 1999; Toyota et
al. 1999; Bird 2002). The hypermethylation of the promoter regions of some genes plays
a pivotal role in the governance of normal and disease development (Baylin et al. 1998).
It was found that in cancer, promoter hypermethylation is one of the most common
mechanisms for the loss of function of tumor suppressor genes. In virtually every type of
human neoplasm, promoter methylation is found to be associated with the inappropriate
transcriptional silencing of genes (Baylin and Herman 2000; Warnecke and Bestor 2000).
Because of the enormous potential of epigenetic markers in both cancer screening and
treatment, considerate effort was made to search for methylated genes that can be novel
therapeutic targets or screening biomarkers (Hayatsu et al. 1970; Frommer et al. 1992;
Herman et al. 1996; Sadri et al. 1996; Gonzalgo and Jones 1997; Xiong and Laird 1997;
Eads et al. 2000; Cottrell and Laird 2003; Tost et al. 2003; Zeschnigk et al. 2004).
Most of existing methods for methylation analysis are based on bisulfite
treatment that converts cytosine to uracil whereas the methylated cytosine residues are
unaltered. The treated DNA is then PCR amplified to yield fragments wherein Ts replace
Us (former Cs), and Cs replace the methylated Cs. Thereafter, the methylation status of
the target DNA is examined using conventional DNA analysis methods. Currently,
methylation-specific PCR (MSP) is the method of choice for methylation analysis
(Herman et al. 1996; Cottrell and Laird 2003), which utilizes methylation-specific
primers to discriminate methylated DNA from unmethylated DNA in PCR. MSP is
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sensitive and can detect one methylated allele in a large background of unmethylated
alleles. Its real time PCR variation can also quantify the abundance of methylated DNA
(Zeschnigk et al. 2004). However, its problem is low throughput. In general, one MSP
reaction reveals methylation of a gene at a time.
Microarray is a method for multiplex analysis. Attempt has been made to use
microarray for high-throughput methylation analysis (Gitan et al. 2002; Kimura et al.
2005; Bibikova et al. 2006; Cheng et al. 2006; Piotrowski et al. 2006). The conventional
application of microarray to methylation analysis involved direct hybridization, utilizing
oligonucleotide probes designed to target either the methylated or unmethylated alleles
within target sequences (Gitan et al. 2002). However, its poor specificity makes it
impossible for it to be used in routine methylation analysis. It is not totally surprised to
see that it is a challenge to apply microarray to methylation analysis. This is because
bisulfite treatment eliminates all Cs in unmethylated DNA and in non-CpG sites of
methylated DNA and thus creates a nearly all C-less sequence of most 3-base-DNA
having predominantly A, G, and T. This reduction in sequences, relative to normal
4-base-DNA, makes hybridization less specific. Because of this problem, each of the
conventional genetic analysis methods must be carefully examined to determine if it is
suitable for methylation analysis.
Recently, we conducted a systematic study to examine the use of microarray
methods for methylation analysis and one of the methods that we tested was SBE-TAGs
microarray, which was originally developed for SNP analysis (Pastinen et al. 1997;
Hirschhorn et al. 2000; Lindroos et al. 2002; Lovmar et al. 2003; Favis et al. 2004; Fan et
al. 2006). We found that SBE-TAGs microarray performed quite well in methylation
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analysis and could reveal the methylation status of the individual CpG sites, thus the
methylation status of the corresponding genes. Importantly, SBE-TAGs microarray
allows for the simultaneous determination of the methylation status of multiple genes. In
addition, SBE-TAGs microarray is robust and reproducible. Clearly, this study
established that SBE-TAGs microarray is an effective microarray method for multiplex
methylation analysis.
4.3 Materials and Methods
4.3.1 Samples and DNA Isolation
Unmethylated control genomic DNA and methylated control genomic DNA
were purchased with CpGenomeTM DNA modification Kit (Millipore, Billerica, MA).
The mixture samples containing both methylated and unmethylated DNA were created by
spiking methylated DNA control genomic DNA into unmethylated control genomic DNA
at a given ratio. The colorectal carcinoma cell lines HCT116 and HTB38 were cultured
under standard conditions and genomic DNA were extracted from the cells using
QIAamp DNA mini kits (QIAGEN, Valencia, CA) according to the manufacturer’s
protocol.
4.3.2 Bisulfite Treatment
The CpGenomeTM DNA modification Kit (Millipore, Billerica, MA) was used
for bisulfite treatment in this study. Bisufite treatment was performed using the protocol
suggested by the manufacturer. The only exception was the desalting and desulfonation
step. Briefly, after bisulfite treatment for 15 h at 50oC, a 50K Microcon centrifuge column
(Millipore, Billerica, MA) was used in desalting, followed by washing the column 3
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times with 500μL ddH2O on Eppendorf Centrifuge 5415C (Eppendorf North America,
Westbury, NY) at 9000RPM . In the desulfonation step, we transferred 500μL of
0.1MNaOH solution to the column, and then spun it until the solution went through at
3000RPM. The column was then washed twice with 500μL of ddH2O and 1 time TE
buffer. Finally, the modified DNA was recovered from the column. The converted DNA
was used immediately or stored at -20oC for further analysis.
4.3.3 Multiplex PCR
The first PCR contained 2μL of bisulfite-converted DNA, 300-400nM of each
primer, 1× AmpliTaq Gold PCR buffer, 400 μM of each dNTP, 4 mM MgCl2, and 2.5 U
AmpliTaq Gold polymerase (Applied Biosystems, Foster City, CA). The first run of PCR
was performed at 95oC for 10min, then 42 cycles of 95oC for 30 sec, 58oC for 45 sec,
72oC for 45 sec and a final extension at 72oC for 5 min on iCycler Thermal Cycler
(Bio-Rad Laboratories, Hercules, CA). The second run of PCR contained 0.5μL of
template DNA produced from the first PCR, 400 nM universal primer (T3
AATTAACCCTCACTAAAGGG; T7 GTAATACGACTCACTATAGG), 1× AmpliTaq
Gold PCR buffer, 400 μM of each dNTP, 4 mM MgCl2, and 2.5 U AmpliTaq Gold
polymerase. The second PCR were carried out at 95oC for 10min, then 35 cycles of 95oC
for 30 sec, 57oC for 30 sec, 72oC for 30 sec and a final extension at 72oC for 5 min.
4.3.4 Multiplex SBE
The final PCR product (4μL) was first treated with 1U/μL Exonuclease I and
0.1U/μL shrimp alkaline phosphatase (USB Corporation, Cleveland, OH) at 37oC for 60
min, followed by inactivation of the enzyme at 95oC for 10min. The SBE reaction was
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performed in a multiplex manner, containing all SBE primers (10nM each), 0.1μM of
Cy3-ddATP, 0.1μM of Cy5-ddGTP (PerkinElmer,Waltham, MA), 0.05U/μL of
ThermoSequenase, 1× SBE buffer (GE healthcare, Piscataway, NJ). The cyclic reactions
were performed for 94oC 5min, followed by 60 cycles of 94oC and 55oC for 30 sec each.
4.3.5 Array Fabrication
Microarray used was home-made. Briefly, synthetic oligonucleotides with 3C
amino linker at 3’ terminal (MWG-Biotech, Piscataway, NJ) were dissolved in 3XSSC,
0.05% SDS, and 0.001% Chaps (Sigma-Aldrich, St. Louis, MO) spotting solution, as this
buffer could improve immobilization of oligonucleotides on an aldehyde modified slide
(CEL Associates, Pearland, TX). The oligonucleotides were spotted on the slides using
XactII Compact Microarrayer (LabNEXT Inc., Glenview, IL). After printing, the slides
were placed in a box at a 75%~100% relative humidity for 12~72 h at room temperature.
Then, the excess of aldehyde-reactive groups were deactivated by incubating the slides
with Pronto! Pre-Soak solution (Corning, NY) for 25 min., followed by washing the
slides with dH2O several times.
4.3.6 Hybridization
After SBE, 1μL of the SBE product, 1μL of 10mg/ml salmon sperm DNA, 8μL
of 10×PCR buffer (GE healthcare, Piscataway, NJ) that was used as hybridization buffer,
and 70μL of dH2O are mixed together, followed by denaturing the mixture solution at
95oC for 5 min. Then, the solution was added to the ProPlate™ Multi-Array Slide System
(Grace Bio-Labs, Bend, OR) and incubated with the slide at 56oC for 3~5 h. After
hybridization, the slides were rinsed with 2×SSC, 1×SSC, 0.5×SSC, and ddH2O,
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respectively. Finally, the slides were spun dry immediately for 5 min at 200×g before
signal detection.
4.3.7 Signal Detection and Data Analysis
Fluorescence signal from each spot of microarray was detected with Typhoon
9410 (GE healthcare, Piscataway, NJ) using the excitation laser: Green (532 nm) and Red
(633 nm). The images acquired by the scanner were analyzed with the software
ArrayVision 8.0 (GE healthcare, Piscataway, NJ). The signal intensity from each spot was
corrected by subtracting the average background from the mean average intensity for
each spot. The data generated from ArrayVision was exported to Microsoft Excel for
further analysis. The methylation level of a target CpG site was calculated by dividing the
methylation signal intensity (Cy5 signal) by the sum of the signal of both methylation
(Cy5)

and

unmethylation

(Cy3):

Percentage

of

Methylation

=

Signal

Cy5/(SignalCy3+SignalCy5).

4.3.8 MALDI-TOF Based Mini-Sequencing
MALDI-TOF based mini-sequencing was used to verify the result of SBE-TAGs.
Briefly, mini-sequencing was first carried out in the presence 0.2μM of ddA, ddT, and
ddC, and 1μM of dG. The concentration of each mini-sequencing primer is 200nM. Other
mini-sequencing conditions were similar to those used in SBE. Thereafter, the MALDI
sample was prepared as described previously (Sun et al. 2000). The sample was then
analyzed using MALDI-TOF (Bruker Daltonics Inc., Billerica, MA). The negative ion
mode was used to collect all spectra.
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4.4 Results and Discussion
4.4.1 Assay Design
SBE-TAGs microarray was originally developed for multiplex SNP genotyping.
In this work, we modified it for multiplex methylation analysis. Fig. 10 displays the
schematic representation of multiplex methylation analysis with SBE-TAGs microarray.
Briefly, a sample is first subjected to bisulfite treatment that converts cytosine to uracil
whereas the methylated cytosine residues are unaltered. The treated DNA is then
amplified by two-runs of multiplex PCR to yield DNA fragments wherein Ts replace Us
(former Cs), and Cs replace the methylated Cs. Thereafter, the methylation status of each
target CpG site is determined using SBE-TAGs microarray, in which single base
extension (SBE) is performed involving extension of a SBE primer located adjacent to
the C position of a target CpG site using DNA polymerase in the presence of the
fluorescence labeled Cy3-ddATP and Cy5-ddGTP, resulting in extension of the
methylated allele by Cy5-ddGTP and extension of the unmethylated allele by
Cy3-ddATP.
The detection of SBE products is achieved with a tag array. Briefly, a unique
sequence tag is added to the 5’ end of each SBE primer, allowing for specific
hybridization with one probe spotted on the microarray. Each of the spotted probes is
complementary only to one sequence tag added to the SBE primers. As a result, all SBE
reactions can be distinguished and detected by a single microarray.
10 CpG sites in 9 different genes were studied to examine the performance of
SBE-TAG microarray. In this study, we use only one SBE primer to target one CpG site
in each gene, except for p16 in which two SBE primers were used to target two different
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Fig. 10 Schematic representation of SBE-TAGs microarray for multiplex
methylation analysis. Two hypothetical CpG sites 1 and 2 are designed as methylated
and unmethylated, respectively. After bisulfite conversion, all of modified DNA template
is amplified by using the primers containing the gene-specific 3’ portion and an upstream
universal sequence (highlighted in blue) in the first PCR. Introduction of this universal
sequence allows for the amplification of all target sequences in the second PCR by using
the same universal primers. In the multiplex SBE reactions, the SBE primers, one for
each target CpG site, are extended in the presence of Cy5-ddGTP and Cy3-ddATP, where
Cy5-ddGTP is added to the SBE primers when the allele is methylated, while Cy3-ddATP
is added to the SBE primers if the allele is unmethylated, respectively. Each SBE primer
is also tagged with one specific sequence tail that is fully complementary to the sequence
of a detection probe spotted on microarray. The labeled SBE products are analyzed by
microarray. The methylation status of a target CpG site is determined on the basis of the
signals of Cy5 and Cy3 emitted from its corresponding spots on microarray.
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CpG sites.
4.4.2 Multiplex PCR Amplification and SBE
Multiplexed PCR is essential to multiplex methylation analysis, but multiplexed
PCR of the bisulfite treated DNA is a challenge. Bisulfite treatment eliminates all Cs in
unmethylated DNA and in non-CpG sites of methylated DNA and thus creates a nearly all
C-less sequence of most 3-base-DNA having predominantly A, G, and T. This reduction
in sequences, relative to normal 4-base-DNA, makes multiplexed PCR of bisulfite treated
DNA difficulty. A two-run PCR strategy is used in this work. The first PCR primers have
both a target-specific part and universal tail part. The target-specific part allows for
amplification of a specific sequence, while the tail part introduces the universal
sequences for the second run of PCR that employs universal primers complementary to
the tail parts introduced by the first run of PCR. The T7 and T3 sequences were used as
the universal tail of the forward and reverse primers for the second PCR, respectively.
The target-specific part of the first PCR primers was designed to tolerate internal CpG
sites to allow its hybridization to both methylated and unmethylated sequences. Because
the first run of PCR is intended to produce sufficient amounts of methylated DNA
molecules for the enrichment step (note that amplification is mainly achieved in the
second run of PCR in this two-staged multiplexing PCR strategy), its amplification is not
requested to be as efficient as conventional PCR. As a result, this reduces the difficulty of
designing the PCR primers. In general, the target-specific part of the primers was
designed to target the regions containing a number of cytosines, but without CpG sites.
When the CpG site cannot be avoided in some cases, the PCR primers were designed to
contain both C and T or both G and A in the C position of the CpG sites. Table II lists 9
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Table II List of the Sequences of the Primers Used in the First PCR.
Primer Forward Primer
Set
MGMT T7-TTTYGGATATGTTGGGATAGTT

Reverse Primer
T3-AAACRACCCAAACACTCACCAAATC

Size
(bp)
109

GATA4 T7-GGTTTGTTTTATTTTTAGGGCGGAGG

T3-CATCCCGAACTACCCTACTAAATCCC

119

HLTF

T3-AACCGAAAACTCCATACTACTCCCC

124

T3-ACTACCATCCAAATAAAAACRACC

135

T7-GTTGGTTATTAGAGGGTGGGGCGGA

SOCS1 T7-GAGTTYGTGGGTATTTTTTTGGTG
p16

T7-TGGAGTTTTYGGTTGATTGGTTGGTTA T3-CTACAAACCCTCTACCCACCTAAATC

144

RASSF2 T7-GTTTGTTTAGTTTGGTTGGATTTGAGTT T3-CTTACCTTCACCCCGAACCAACTACATC 150
CHFR

T7-ATTAAGAGCGGTAGTTAAAGCGGAGT T3-TCCCTTCTACCCCAACATAACATAAC

156

Reprimo T7-TTTTGGGAAATTTTTACGGTTTAGGGAT T3-TCGCTACTATTAACCAAAAACAAACCC 225
TPEF

T7-TYGTGTTTTGTTGTTGTTGTTTTTTTGA T3- ATAAACTACCCGCACACTCATATACCAT 198
TATTTT

TC

Y is the combination of C and T.
R is the combination of G and A

.
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pairs of primers used in this work, where Y and R indicates that the primer contains either
both C and T or both G and A at that given base.
In the same way, SBE was carried out in a multiplex manner. In other words, all
10 SBE reactions were performed in the same reaction tube. Prior to multiplex SBE, all
of the SBE primers listed in table III were tested individually to check their performance
and specificity. It is noted that the SBE primers were also designed to have both C and T
or both G and A in the C position of the CpG sites in the case where there are CpG sites
located within the sequences covered by the SBE primer sequences.
4.4.3 Tag Sequence Selection
Selection of highly discriminative sequences that can be used as the tags is
critically important to SBE-TAGs microarray. During the course of this work, we found
that many of the tag sequences reported in the literatures could still interact with each
other, creating a high background that reduces the effectiveness of SBE-TAGs microarray.
Hence, we first conducted a study to experimentally search for a set of good sequence
tags. This is achieved by using a SBE method. Briefly, a synthesized oligo was used as
the template for SBE. Each of the SBE primers consists of an identical sequence
complementary to the sequence of the template and a unique sequence tag selected from
70 candidate sequences (Favis et al. 2004). After the SBE reaction, all of the products
with fluorescence labeling were hybridized on microarray slides with candidate
sequences individually. We examined each of the 70 sequences to determine whether it
has cross-hybridization with other sequences. With the selection criteria of signal/noise >
10 folds, we were able to select 32 highly discriminative sequences from the 70
sequences.
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Table III. List of the Sequences of the SBE and Mini-Sequencing Primers.
Primer Set

Microarray SBE primer

MALDI-TOF Mini-Sequencing primer

MGMT

TCRAAACRCAAAACRTTCTAAAAAC

GCAAAACGTTCTAAAAAC

GATA4

CCAAACRCRACCCCACCRAAACTACC

GACCCCACCGAAACTACC

HLTF

CRCTACCTACTCTCCCCCTCTCC

CCTACTCTCCCCCTCTCC

p16_1

CACCTCCTCTACCCRACCCC

CCTCCTCTACCCGACCCC

p16_2

CCCCCRCCTCCAACAACRCCC

CCGCCTCCAACAACGCCC

SOCS1

AAAAAACAATTCCRCTAACRACTATC

ATTCCGCTAACGACTATC

RASSF2

ACTTCAACTACRCCTCRACCAAC

AACTACGCCTCGACCAAC

CHFR

CCTTCTACCCCAACATAACATAAC

ACCCCAACATAACATAAC

TPEF

CCRCTCCAAAACRCCCCCTACC

TCCAAAACGCCCCCTACC

Reprimo

CRAAAACTCCTCRCTCTACTTTC

ACTCCTCGCTCTACTTTC

R is the combination of G and A.
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Fig. 11 Analysis of Control DNA
with SBE-TAGs Microarray.
(A) Typical array spectra obtained
from the samples containing 0%,
10%, 30%, 50%, 70%, and 100%
of methylated DNA. The green
color shows the signal of Cy3 (the
signal of the unmethylated allele)
and the red color is the signal of
Cy5 (the signal of the methylated
allele). The intensity of the two
channels reflects the difference in
the degree of methylation; (B)
The printing pattern of the 10
probes spotted on microarray, in
which three spots were printed for
each probe and one probe detects
methylation in one CpG site.
Other than gene of p16 in which
two CpG sites are targeted, only
one CpG site is targeted in 8 other
genes;
(C)
The
standard
calibration curves (plot of
M/(M+U) vs. the percentage of
methylated DNA) for all 10
targeted CpG sites.
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4.4.4 Analysis of Control DNA with SBE-TAGs Microarray
We first studied the DNA samples containing control genomic DNA to generate
criteria for determining the methylation status of each target CpG. Each CpG site in
methylated control DNA is methylated, while each CpG site is unmethylated in
unmethylated control DNA. The samples containing 0%, 10%, 30%, 50%, 70%, and
100% of methylated DNA were used in this study, respectively, where the samples
containing both methylated and unmethylated DNA were created by spiking methylated
control genomic DNA into unmethylated control genomic DNA.
The array spectra obtained from each sample were showed in Fig. 11A. Each
array was printed with the fixed printing pattern shown in Fig. 11B and each probe was
spotted on three positions to generate the average signal. It is seen that the Cy3
(unmethylated) signal (the top panel spectra of Fig. 11A) decreased while the Cy5
(methylated) signal (the bottom panel spectra of Fig. 11A) increases from left to right.
This is consistent with the fact that the concentration of methylated DNA increased from
left to right in the tested samples. It is also seen that the background signal still appears in
the arrays even after we used highly discriminated tag probes. For example, the array
spots for the CpG sites of p16_2, TPEF, and GATA4 yield the signal in the Cy5 channel
when the sample containing no methylated DNA was used. The array spots corresponding
to the CpG sites of CHFR, RASSF2, HLTF, and p16_2 yields the signal in the Cy3
channel when the sample containing 100% of methylated DNA was used. One possible
source for this background signal is cross-hybridization between the extension part of a
SBE primer with the probes targeting other SBE reactions.
Nevertheless, we found that the SBE-TAG microarray can still distinguish
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methylated DNA from unmethylated DNA even in the presence of this background if we
utilize the following quantitative approach. Briefly, the average signal of a methylated (M)
allele or its unmethylated (U) allele of a target CpG site was first derived from three spots.
The signals were then used to calculate the ratio of M/(M+U) or Cy5/(Cy5+Cy3), where
the M/(M+U) ratio represents the methylation level or the percentage of the methylated
allele in a CpG site. The ratio of M/(M+U) for each target CpG site was plotted vs. the
percentage of methylated DNA to establish the standard calibration curves (Fig. 11C ).
It was seen from Fig. 11C that for each target CpG site, there is a good linear
relationship between M/(M+U) and the percentage of methylated DNA, and that
M/(M+U) increased proportionally with the percentage of methylated DNA in the
samples. We repeated this calibration at least four times and found that SBE-TAGS was
robust and reproducible. This result shows that SBE-TAGs microarray in conjunction
with the standard calibration approach can be used for multiplex methylation analysis.
4.4.5 Analysis of Methylation of Cell Line DNA with SBE-TAGs Microarray
Next, we utilize the calibration curves developed above to analyze the
methylation status of DNA in two colorectal cancer cell lines of HCT116 and HTB38.
HCT116 has been subjected to the comprehensive methylation analysis (Liang et al. 2000;
Akiyama et al. 2003; Kondo et al. 2003; Akinoet al. 2005; Brandes et al. 2005; Mund et
al. 2005; Takahashi et al. 2005; Takahashi et al. 2006), allowing us to examine the
accuracy of the SBE-TAGs assay by comparing our result with the published data.
HTB38 was rarely studied for its methylation and this work can yield insights into
methylation of HTB38.
Fig. 12 shows the results of four separate studies of HCT116 and HTB38. The
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Fig. 12 Using SBE-TAGs microarray for cell lines analysis. Array spectra obtained
from analysis of cell lines of HCT116 (A) and HTB38 (B). Each cell line sample was
independently studied four times.
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signal of a probe in each array was averaged from 3 spots to determine the ratio of
M/(M+U). The mean values of M/(M+U) were determined from four separate arrays and
are listed in Table IV. It is seen that the SD (Standard Deviations) of the mean of
M/(M+U) for all target CpG sites are between 2.4E-03 and 1.6E-05, establishing that the
SBE-TAGs assay is reproducible. We also used the standard curves derived from Fig 11C
to determine the methylation status of the 10 target CpG sites and found that in HCT116,
8 of 9 genes and 9 of 10 CpG sites were methylated with the exception of RASSF2. This
finding is in good agreement with the reported methylation level in HCT116. For
example, published studies shown that RASSF2 is unmethylated while, other eight genes
are methylated in HCT116 (Liang et al. 2000; Akiyama et al. 2003; Kondo et al. 2003;
Akinoet al. 2005; Brandes et al. 2005; Mund et al. 2005; Takahashi et al. 2005; Takahashi
et al. 2006). In HTB38, 8 of 9 genes (9 of 10 CpG sites) were found methylated, while
MGMT was unmethylated. The main difference between HCT116 and HTB38 is that
RASSF2 is unmethylated in HCT116, while MGMT is unmethylated in HTB38.
4.4.6 Methylation Status Validation by MALDI-TOF based Mini-sequencing
We also carried out a study of using MALDI-TOF based mini-sequencing (Sun
et al. 2000) to determine the methylation status of the 10 target CpG sites in HCT116 and
HTB38. MALDI-TOF can directly determine the molecular weight of mini-sequencing
products without hybridization, eliminating any potential effects of cross-hybridization
on methylation analysis. Hence, the MALDI-TOF based analysis can provide additional
insights into the accuracy of SBE-TAGs microarray. Each mini-sequencing primer used is
the same to the extension part of the corresponding SBE primer. In other words,
mini-sequencing primers target the same CpG sites, but without the tag tail used in the
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Table IV. Results of Analyzing 10 CpG Sites of 9 Genes in HCT116 and HTB38.
HCT116

p16_1
RASSF2
HLTF
SOCS1
MGMT
CHFR
GATA4
p16_2
TPEF
Reprimo

HTB38

Mean of
M/(M+U)

SD

Mean of
M/(M+U)

SD

0.788

9.80E-05

0.913

1.40E-04

0.123

1.60E-04

0.893

5.60E-05

0.215

2.90E-04

0.775

2.60E-04

0.893

1.60E-04

0.587

9.20E-04

0.334

1.20E-03

0.028

1.60E-05

0.839

3.80E-04

0.45

1.90E-03

0.943

1.30E-04

0.877

2.60E-04

0.549

2.40E-03

0.919

3.60E-05

0.935

8.60E-05

0.888

1.70E-04

0.303

1.50E-03

0.879

4.40E-04
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Fig. 13 Typical MALDI-TOF spectra obtained from analysis of HCT116 and HTB38.
Peak labeled by P, U, and M correspond to the primer peak, the peak extended from the
unmethylated allele, and the peak extended from the methylated allele, respectively. (A)
Analysis of HLTF in HCT116; (B) Analysis of HLTF in HTB38; (C) Analysis of MGMT
in HCT116; (D) Analysis of MGMT in HTB38; (E) Analysis of RASSF2 in HCT116; (F)
Analysis of RASSF2 in HTB38.
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SBE primer. In addition, each CpG site was individually studied by MALDI-TOF. The
result of MALDI-TOF based mini-sequencing was consistent with the result of
SBE-TAGs. Several representative mass spectra obtained from MALDI-TOF were
showed in Fig. 13. Figs. 13A and 13B shows the result of analyzing the targeted CpG site
of HLTF in HCT116 and HTB38, respectively, where the M peak (methylated) was seen
in both spectra, indicating that HLTF is methylated in both cell lines. Figs. 13C and 13D
shows the results of analyzing the CpG site of MGMT in both HCT116 and HTB38,
respectively, where only Fig. 13C has the observable M peak, indicating that MGMT is
methylated in HCT116, but unmethylated in HTB38. Figs. 13E and 13F shows the results
of analyzing the CpG site of RASSF2 in both HCT116 and HTB38, respectively, where
only Fig. 4F has the observable M peak, indicating that MGMT is methylated in HTB38,
but unmethylated in HCT116. Clearly, this MALDI-TOF mini-sequencing study further
confirms that SBE-TAGs microarray is reliable and can accurately determine the
methylation status of many genes in a multiplex manner.
In conclusion, the SBE-TAGs microarray assay described in this report can
accurately determine the methylation status of a number of CpG sites in a multiplexing
manner. In addition, this SBE-TAGs microarray is robust and reproducible. Clearly, this
work establishes that SBE-TAGs microarray is an effective method for multiplex
methylation analysis.
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CHAPTER V

CHZMA: A NOVEL MICROARRAY METHOD FOR MULTIPLEX
METHYLATION ANALYSIS OF TUMOR TISSUE SAMPLES

5.1 Abstract
Multiplex analysis of methylation in tumor tissue samples has been a challenge.
This report describes a novel approach called Competing-Hybridization-ZipcodeMicroArray (CHZMA) for multiplex methylation analysis of tumor tissue samples, which
is based on two steps of hybridization to achieve the specific detection of methylation on
microarray. On the basis of analysis of seven genes (MGMT, GATA4, HLTF, SOCS1,
RASSF2, ER, 3-OST-2), we found that the CHZMA assay can robustly detect
methylation in the samples containing as low as 10% of methylated DNA. In addition, the
CHZMA assay is validated with breast tumor tissues samples. This work suggests that
CHZMA can be a new method in place of MSP for methylation analysis of tumor tissue
samples.
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5.2 Introduction
Because of the enormous potential of epigenetic markers in both cancer
screening and treatment, considerable effort has been made to search for methylated
genes that can be novel therapeutic targets or screening biomarkers (Mori et al. 2006; Liu
et al. 2007; Schuebel et al. 2007). The commonly used approach to identify methylated
genes in cancer consists of two steps. The first is to identify the genes that are
underexpressed in cancer through gene expression of cell lines. The second step is to
determine which genes among the candidate genes discovered in the first step are
silenced by methylation and how they are associated with cancer. This is achieved by
analysis of a number of non-tumor tissue and tumor tissue samples.
Most of existing methods for methylation analysis are based on bisulfite
treatment that converts cytosine to uracil whereas the methylated cytosine residues are
unaltered. The treated DNA is then PCR amplified wherein Ts replace Us (former Cs),
and Cs replace the methylated Cs. Thereafter, methylation analysis is performed using
conventional genetic analysis methods. Although other methods are available (Toyota et
al. 1999), the most commonly used methylation analysis method has been
methylation-specific PCR (MSP) (Herman et al. 1996) or its real-time PCR variation
(Eads et al. 2000) because of its high sensitivity and simplicity. However, the problem of
MSP is its low throughput. In general, one MSP reaction reveals methylation of a gene at
a time. This weakness has prevented one from performing large-scale methylation
analysis.
Microarray allows for parallel evaluation of the methylation status at numerous
CpG sites within multiple genes of interest. The early application of microarray to
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methylation analysis involved direct hybridization, utilizing oligonucleotide probes to
target either the methylated or unmethylated alleles within target sequences (Gitan et al.
2002). However, it is not sufficiently sensitive and robust for analysis of tissues
containing low abundance of methylated DNA. Although additional work was done to
improve direct hybridization by designing better probes (Kimura et al. 2005; Piotrowski
et al. 2006), it is still not robust for methylation analysis. Ligation-based microarray
methods were also developed for methylation analysis (Bibikova et al. 2006; Cheng et al.
2006), but they are also not sufficiently robust for methylation analysis of tissue samples.
This is due in part to the fact the specificity of annealing a ligation probe to a given
sequence can vary greatly from one sequence to another (Bibikova et al. 2006, Dahl et al.
2007). Furthermore, bisulfite treatment eliminates all Cs in unmethylated DNA and in
non-CpG sites of methylated DNA and thus creates a nearly all C-less sequence of most
3-base-DNA having predominantly A, G, and T. This reduction in sequences, relative to
normal 4-base-DNA, makes hybridization less specific.
In

this

report,

we

describe

a

novel

method

called

CHZMA

(Competing-Hybridization- Zipcode-MicroArray) for methylation analysis. Unlike other
microarray methods, CHZMA utilizes two steps of hybridization to improve its
specificity. Based on the principle of CHZMA, we have developed a multiplex assay to
simultaneously survey methylation of seven genes in the presence of a 10 folds more
excess of unmethylated DNA, indicating that CHZMA is sufficiently sensitive to detect
methylated DNA in tumor tissue samples.
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5.3 Materials and Methods
5.3.1 Sample Collection and DNA Isolation
Unmethylated control genomic DNA and methylated control genomic DNA
were purchased from Millipore within CpGenomeTM DNA modification Kit (Millipore).
Samples containing both methylated and unmethylated control DNA were created by
spiking methylated control DNA into unmethylated control DNA. Tissue DNA was
extracted from breast tissues samples using a QIAamp DNA mini kit (QIAGEN)
according to the manufacture’s protocol.
5.3.2 Sodium Bisulfite Treatment
The CpGenomeTM DNA modification Kit (Millipore, Billerica, MA) was used
for bisulfite treatment in this study. Bisufite treatment was performed using the protocol
suggested by the manufacturer. The only exception was the desalting and desulfonation
step. Briefly, after bisulfite treatment for 15 h at 50oC, a 50K Microcon centrifuge column
(Millipore, Billerica, MA) was used in desalting, followed by washing the column 3
times with 500μL ddH2O on Eppendorf Centrifuge 5415C (Eppendorf North America,
Westbury, NY) at 9000RPM. In the desulfonation step, we transferred 500μL of
0.1MNaOH solution to the column, and then spun it until the solution went through at
3000RPM. The column was then washed twice with 500μL of ddH2O and 1 time TE
buffer. Finally, the modified DNA was recovered from the column. The converted DNA
was used immediately or stored at -20oC for further analysis.
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5.3.3 Multiplex PCR
The first PCR reaction contained 2μL of bisulfite-converted DNA, 300-400nM
of each primer (Table V), 1× AmpliTaq Gold PCR buffer, 400 μM of each dNTP, 4 mM
MgCl2, and 2.5U of AmpliTaq Gold polymerase (Applied Biosystems, Foster City, CA),
respectively. The first run of PCR was performed at 95oC for 10min, then 42 cycles of
95oC for 30 sec, 58oC for 45 sec, 72oC for 45 sec and a final extension at 72oC for 5 min
on iCycler Thermal Cycler (Bio-Rad Laboratories, Hercules, CA). The second run PCR
reaction contained 0.5μL of the template DNA produced from the first PCR, 400 nM of
each

universal

primer

(T3

AATTAACCCTCACTAAAGGG;

T7

GTAATACGACTCACTA TAGG), 1× AmpliTaq Gold PCR buffer, 400 μM of each dNTP,
4 mM MgCl2, and 2.5 U of AmpliTaq Gold polymerase, respectively. The second PCR
were carried out at 95oC for 10min, then 35 cycles of 95oC for 30 sec, 57oC for 30 sec,
72oC for 30 sec and a final extension at 72oC for 5 min.
5.3.4 Microarray Array Fabrication
Microarray

used

was

home-made.

Briefly,

synthetic

oligonucleotides

(MWG-Biotech, Piscataway, NJ) were dissolved in 3xSSC, 0.05% SDS, and 0.001%
Chaps (Sigma-Aldrich, St. Louis, MO) spotting solution, as this buffer could improve
immobilization of oligonucleotides on an aldehyde modified slide (CEL Associates,
Pearland, TX). The oligonucleotides were spotted on the slides using XactII Compact
Microarrayer (LabNEXT Inc., Glenview, IL). After printing, the slides were placed in a
box at a 75%~100% relative humidity for 12~72 h. Then, the excess of aldehyde-reactive
groups were deactivated by incubating the slides with Prontol Pre-Soak solution
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Table V. PCR Primer Sequences.
Primer Forward Primer
Set
MGMT T7-TTTYGGATATGTTGGGATAGTT

Reverse Primer
T3-AAACRACCCAAACACTCACCAAATC

Size
(bp)
109

GATA4

T7-GGTTTGTTTTATTTTTAGGGCGGAGG

T3-CATCCCGAACTACCCTACTAAATCCC

119

HLTF

T7-GTTGGTTATTAGAGGGTGGGGCGGA

T3-AACCGAAAACTCCATACTACTCCCC

124

SOCS1

T7-GAGTTYGTGGGTATTTTTTTGGTG

T3-ACTACCATCCAAATAAAAACRACC

135

RASSF2 T7-GTTTGTTTAGTTTGGTTGGATTTGAGTT T3-CTTACCTTCACCCCGAACCAACTACATC 150
ER

T7-GAGGTGTATTTGGATAGTAGTAAGTT

T3-AAAAAAACCCCCCAAACCGTTAAAACC 174

3-OST-2

T7-TTTTGGTTAGTAGTTTTCGGAGAAGA

T3-ATAAACCATAACTCCATAAACCCGC

168

ACTB

T7-TGGTGATGGAGGAGGTTTAGTAAGT

T3-AACCAATAAAACCTACTCCTCCCTTAA

133

Y is the combination of C and T.
R is the combination of G and A.
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(Corning, NY) for 25 min., followed by washing the slides with dH2O several times.
5.3.5 Competing Hybridization
A mixture of seven M probes (1μM of each), seven U probes (40-50μM of each),
and an ACTB internal reference probe (1μM) was incubated with the PCR products for
hybridization. Thehybridization was carried out on a PCR cycler by first denaturing DNA
at 95 oC for 5min, followed by stepwise reducing the temperature at 0.1 oC/sec to 72 oC,
then slowly reducing the temperature from 72 oC to 50 oC within 1.5h. Finally the
hybridization temperature was maintained at 50 oC for 30min. The M probes and
competing probes are listed in table VI.
5.3.6 Probe Isolation
6μL of streptavidin-coated magnetic beads (Dynabeads® M-280) were incubated
with the above hybridization solution at the room temperature for one hour, allowing for
bead capturing of the hybrids formed by the probes and PCR products. After washing, the
beads were resuspended in 60μL of the microarray hybridization buffer, followed by
heating the solution at 95 oC for 5min to release the captured probes.
5.3.7 Microarray Hybridization and Data Analysis
The captured probes were spotted on the ProPlate™ Multi-Array Slide System
(Grace Bio-Labs, Inc.). The slide was incubated at 37 oC for 12h. After hybridization, the
slide was rinsed one time each with 2×SSC, 1×SSC, 0.5×SSC, and ddH2O. Finally, the
slide was spun dried immediately for 5 min at 200×g. The fluorescence signal emitted
from an array slide was detected with a Typhoon 9410 (GE healthcare). The images
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Table VI. Sequences of the Probes Used in Competing Hybridization.
Probe Set

Methylation-Specific Detection Probe

Competing Probe

MGMT

Cy5-Zip-Code 1-AAAACCTACGAACGTCGAAA

AAAACCTACAAACATCAAAA

GATA4

Cy5-Zip-Code 2-CGCCCGAAACGCCTCCGAACGC

CACCCAAAACACCTCCAAACAC

HLTF

Cy5-Zip-Code 3-CGCAACCGCCGAACGCACGC

CACAACCACCAAACACACAC

SOCS1

Cy5-Zip-Code 4-CACGCGAATACTCGTAAATCCC

CACACAAATACTCATAAATCCC

RASSF2

Cy5-Zip-Code 5-CGCCTCGACCAACGATCGACGA

CACCTCAACCAACAATCAACAA

ER

Cy5-Zip-Code 6-GCGTTAACGACGACCGCGACG

ACATTAACAACAACCACAACA

3-OST-2

Cy5-Zip Code 7-ACGACCACGCGAATCGAACGTT

ACAACCACACAAATCAAACATT

ACTB

Cy5-Zip-Code 8-ACCACCACCCAACACACAATAAC
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acquired were then analyzed with Software ArrayVision 8.0 (GE healthcare). The signal
intensity from each spot was corrected by subtracting the average background from the
mean average intensity of that spot. The data generated from ArrayVision was exported in
the Excel format for further analysis. The methylation status of a gene of interest was
determined by the ratio of the signal of its corresponding M probe to the signal of the
internal reference gene probe.
5.3.8 Statistical Analysis
The optimal cutoff values for the assignment of the methylation status were
determined by the receiver-operator characteristic (ROC) curve analysis using MedCalc
Software (Mariakerke, Belbium). This is achieved by maximizing both sensitivity and
specificity (Enokida et al. 2005; Hoque et al.2006).
5.3.9 MSP Analysis
Each MSP reaction contained 1~10ng of bisulfite-converted DNA, 400 nM of
each primer, 1×AmpliTaq Gold PCR buffer, 400 μM of each dNTP, 4 mM MgCl2, and 1.5
units of AmpliTaq Gold polymerase (Applied Biosystems). PCR products were examined
on 4% agarose gel.
5.4 Results and Discussion
5.4.1 Principle of CHZMA
Fig. 14 displays the principle of CHZMA. In general, a CHZMA assay consists
of five steps. Firstly, a DNA sample is subject to bisulfite treatment that converts cytosine
to uracil whereas the methylated cytosine residues are resistant to this conversion.
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Fig. 14 Schematic representation of the principle of CHZMA. Two hypothetical CpG
sites 1 and 2 are designed as methylated and unmethylated, respectively. After bisulfite
conversion, the treated DNA is subject to PCR amplification using a gene-specific 3’
portion and an upstream universal sequence (highlighted in blue) in the first PCR. This
universal sequence is used as a PCR primer to amplify all of target genes in the second
PCR. all of the PCR products were labeled with biotin. In the competing hybridization,
only methylated probe and internal reference probe with zip-code sequences were labeled
with Cy5. To improve the hybridization specificity, excessive amount of the competing
probes without zip-code and Cy5 modification were added in the competing system.
After the following solid-phase extraction, only methylation probes and internal reference
could hybridized on microarry slides for the signal detection. The relative methylated
level could be present by the ratio of target gene and internal reference.
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Secondly, the treated DNA is subject to multiplex PCR amplification by using a
two-run PCR, in which all target sequences are first amplified by the first run of PCR.
Each of the primers used in the first PCR has a target-specific part and a universal tail
part. The target-specific part amplifies one of the target genes, while the tail part
introduces a universal sequence for the second run of PCR. In this work, the T7 and T3
sequences are used as the universal tail of the forward and reverse primers, respectively.
Then, the products of the first PCR are further amplified using the T7 and T3 universal
primers. A biotin tag is also added to the PCR products during the course of the second
PCR.
Thirdly, PCR products are incubated with a set of the methylation-specific
detection probes (or M probe) and their respective competing probes (U probe). Each of
the M probes has two parts: a methylation-specific sequence complementary to a
methylated sequence of interest, and a zip-code tag complementary to a zip-code probe
spotted on microarray. In addition, the M probes are labeled by a Cy5 dye. Each of the U
probes only contains a sequence complementary to an unmethylated sequence. In this
step, a competing hybridization scheme is utilized to improve the hybridization
specificity, in which DNA fragments bind to either the M or U probes. The role that the U
probes play herein is to inhibit non-specific hybridization between unmethylated
sequences and the M probes. It was observed that the presence of a greatly more excess
of the U probes could substantially improve the specificity
of hybridization. As a result of this hybridization, the M probes can preferentially bind to
the methylated DNA fragments.
Fourthly, the hybrids formed in Step 3 are captured by solid-phase extraction
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involving the use of streptavidin-coated magnetic bead, as each PCR product contains a
biotin tag. The beads are washed, leading to removal of the un-reacted U and M probes.
Then, the beads are heated to release the probes captured. The result of step 4 is to isolate
the M probes that preferentially bind to the methylated DNA fragments. The quantity of
an M probe captured can reflect the quantity of the methylated allele in a target sequence.
Finally, the methylation status of each target sequence is analyzed using
microarray. This is done by incubating the probes isolated in Steps 3 and 4 with
microarray pre-spotted with a variety of zip-code probes. As mentioned above, the second
part of an M probe is a zip-code tag that is complementary to a zip-code probe spotted on
microarray. Each zip-code tag has a unique sequence containing all four nucleotides of A,
G, T, C, minimizing cross-hybridization. It is noted that the U probes do not contain the
zip-code tag, thus not being captured and detected by microarray. Similar to quantitative
MSP (Harden et al. 2003), CHZMA also utilizes an unmethylated gene, ACTB, as
internal reference to measure the methylation status of a gene. In other words, the
methylation status of a gene is determined on the basis of the signal ratio of its
corresponding M probe to the zip-code probe for detecting ACTB.
5.4.2 Specificity and Sensitivity of CHZMA
We first studied the specificity and sensitivity of CHZMA using the samples
created by spiking methylated control DNA into unmethylated control DNA. The
methylated status at each CpG site is known in control DNA. Seven genes were selected
for this study and they were MGMT, GATA4, HLTF, SOCS1, RASSF2, ER, 3-OST-2,
respectively. Only one methylation-specific detection probe was used to determine the
methylation status of one target gene. The samples containing 0%, 3%, 5%, 10%, 50%,
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and 100% of methylated DNA were studied, respectively. We found that the specificity of
hybridization involved in Step 3 was poor in the absence ofthe U probes, but the presence
of an excessive amount of the U probes greatly improved the specificity. Fig. 15A shows
the result when the same quantity of the M and U probes were used, while Fig. 15B
shows the result when a 40-folds more excess of the U probes were present. It was seen
that the presence of a 40-50 folds more excess of the U probes led to the best
discrimination. Hence, a 40 fold more excess of the U probes were used in the remaining
of this study.
Experimentally, we first determine the background signal (Rb), i.e. the signal
ratio of a M probe to the internal reference gene probe when no methylated DNA is
present. Then, we measured the same signal ratio (R) in the samples containing 3%, 5%,
10%, 25%, and 50% of methylated DNA, respectively. Table VII lists the result of the
statistical analysis of the CHZMA assay when it was used to analyze the samples
containing 0% or 10% of methylated DNA, respectively. Each of the samples was
analyzed 25 times. Then, we determined the average signal ratios of R and Rb for each
gene. It was seen that in each case, the R value determined for the samples containing
10% of mehtylated DNA is about 3 times or more larger than Rb. Statistical analysis also
suggests that the difference between R and Rb is statistically significant with the p value
of less than 1.9X10-5 in all seven genes, suggesting that CHMZA is still robust to detect
all methylated genes if the samples contain only 10% of methylated DNA. It was noted
that in some cases, CHZMA could detect as little as 3% of methylated DNA.
Receiver operating characteristics (ROC) curve (plotting sensitivity vs.
100-specificity) is a useful method to evaluate the performance of a diagnostic test in
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Fig. 15 Effect of amounts of the U probes on the specificity of hybridization. (A) The
molar quantity of an M probe used in hybridization is the same to that of its
corresponding U probe; (B) a 40 folds more excess of the U probe than the M probe was
used in hybridization; (C) The fixed printing pattern of 8 zip-code probes spotted on a
assay slide. Seven probes are used to detect seven genes (one for each gene) and the
eighth probe is for the detection of the internal reference gene, ATCB.
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Table VII. Statistical Analysis of the Performance of CHZMA.
100% Specificity
Rb

R

MGMT

0.248

0.631

GATA4

0.141

HLTF

P-value

100% Sensitivity

1.5X10-13

Cutoff
Valuea
0.382

Sensitivity
%
88

Cutoff
Valueb
0.364

Specificity
%
88

0.716

7.8X10-10

0.249

96

0.226

88

0.253

1.775

2.0X10-15

0.526

100

0.526

100

SOCS1

0.070

0.370

1.1X10-07

0.144

100

0.144

100

RASSF2

0.075

0.425

1.9X10-05

0.142

92

0.123

96

ER

0.082

0.295

3.1X10-23

0.121

100

0.121

100

3-OST-2

0.490

1.886

1.7X10-20

0.856

100

0.856

100

Cutoff Valuea is determined at 100% specificity.
Cutoff Valueb is determined at 100% sensitivity.
Rb is the ratio of unmethylated control DNA, and R is the ratio of 10% methylated
control DNA.
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Fig. 16 ROC curve. Representative receiver-operator characteristic (ROC) curves for
analysis of MGMT (left) and GATA4 (right).
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Hoque et al. 2006), in which the sensitivity and specificity of an assay can be determined
on the basis of the cutoff value. Fig. 16 shows the representative ROC curves for analysis
of MGMT and GATA4, respectively. The curves were obtained for the samples
containing 10% of methylated DNA.
In this study, the optimum cutoff values, maximizing the sum of sensitivity and
specificity, were derived. Sensitivity is defined as the percentage of the samples that are
correctly identified as methylated in the samples containing the same abundance of
methylated DNA. Specificity is defined as the percentage of the samples that are
correctly called as unmethylated in the samples containing only unmehtylated DNA.
Table 3 lists the cutoff values when the samples contain 10% of methylated DNA at
100% of sensitivity and 100% of specificity, respectively. As seen from Table 3, with a
specificity of 100%, CHZMA has a sensitivity of 88% (MGMT), 92% (RASSF2), 96%
(GATA4), and 100% (HLTF, SOCS1, ER, and 3-OST-2), respectively. With a sensitivity
of 100%, CHZMA has a specificity of 88% (MGMT), 96% (RASSF2), 88% (GATA4),
and 100% (HLTF, SOCS1, ER, and 3-OST-2), respectively.
5.4.3 Analysis of Breast Cancer Tissues
The CHZMA assay developed in this work can robustly reveal methylation in
the samples containing as little as 10% of methylation DNA, allowing for methylation
analysis of tumor tissues. Hence, we next apply this assay to analysis of 5 normal breast
tissues and 11 breast cancer tissues. The DNA extracted from the tissue samples was
subject the CHZMA analysis in the same manner as outlined above. Briefly, after the
microarray data analysis, the methylation status of each gene in each sample was
classified using the cutoff values (100% of specificity) listed in Table 3. In other words,
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Table VIII. Methylated Primer Sets for Methylation-Specific PCR.
Primer set

Forward Primer

Reverse Primer

MGMT

CGTTTCGACGTTCGTAGGTTTTCGC AACCACTCGAAACTACCACCGTCC

Size
Anneal
(bp) Temperature
121
60℃

GATA4

GGTTTTGCGTTCGGAGGCGTTTC

ATAAACGACTCCGTCGACTCCCG

120

66℃

HLTF

GATCGCGTGCGTTCGGCGGTT

GACCCCGAACCGCGACCGTAA

132

64℃

SOCS1

CGCGTGTATTTTTAGGTCGGTCGT

GCGAAACTCTTCCCGACGAATAAA

117

59.5℃

RASSF2

TTCGTCGATCGTTGGTCGAGGC

CGCGCCTTACCTTCACCCCGA

124

64℃

ER

TCGCGGTCGTCGTTAACGCGTA

AACGAACTCGAAAACACGCTATTAAAT 133

60℃

3-OST-2

TAACGTTCGATTCGCGTGGTCGT

AACTCCATAAACCCGCGCCGAAA

60℃
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for a given gene, this gene is called methylated if its measured R value is larger than the
corresponding cutoff value, otherwise this gene is called unmethylated. Fig. 17A displays
the result of analyzing the 16 tissue samples. The red color indicates that the measure R
value for a given gene is larger than its correposning cutoff value, thus reveal that this
gene is methylated in a sample of interest. The green color indicates that a gene is
unmethylated in a tissue sample of interest. 90.9% (10 of 11) of cancer samples were
found methylated in at least one target gene, while only one normal tissue of S5 was
methylated in ER, 3-OST-2, and GATA4. It has reported that aging can also cause
methyaiton in ER, 3-OST-2, and GATA4 (Issa et al. 1997; Takahashi et al. 2006). Hence,
it is not totally surprised to observe methylated ER in a normal breast tissue.
To validate the result of CHAZM, we also used MSP to determine the
methylation status of the same seven genes in two tissue samples of S8 and S9, in which,
one of the two primers used in a MSP reaction was designed to target the same sequence
covered by an M probe, allowing for the direct comparison of MSN with CHZMA. In
addition, only MSP reactions for detecting methylated DNA were performed and ach
gene was individually studied by MSP. The MSP result was shown in Fig. 17B. It is seen
that the MSP result is concordant with the methylaiton status determined by CHAMZ,
except for the case of 3-OST-2 in the sample of S9, where MSP revealed that 3-OST-2
was methylation, while 3-OST-2 was called unmethylated by CHZMA. This discrepancy
may be due to the difference in the detection sensitivity. MSP is highly sensitive and can
detect one methylated allele in 1,000 copies of unmethylated alleles (Eads et al. 2000),
while CHZMA is robust to detect 10% or higher abundance of methylated DNA. During
the course of this work, we found that the methylation level can vary greatly from gene to
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Fig. 17 Methylation analysis of tissue samples. (A) The result of analysis of 5 normal
breast tissues (S1-S5) and 11 breast cancer tissues (S6-S16) with the CHZMA assay, in
which the measured R value for each target gene in a given tissue samples is listed. The
red color indicates that the measure R value for a gene is larger than the its correposning
cutoff values, while the green color indicates that the R value for a gene is smaller than
the corresponding cutoff value. (B) MSP analysis of Samples S8 and S9. A clear band
suggests that the corresponding gene is methylated in tissue. Otherwise the gene is
unmethylated.
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gene even in the tissue sample. The abundance of the methylated gene of 3-OST-2 may
simply be lower than 10% in Sample of S9 and thus cannot be detected by CHZMA.
Clearly, this study demonstrates that CHZMA is a reliable method for
methylation analysis, which can robustly detect as low as 10% of methylated DNA. In
principle, the number of target sequences that can be simultaneously amplified by PCR
limits the throughput of a CHZMA assay. During the course of this study, we found that
the PCR strategy used in this work can simultaneously amplify more than 10 different
sequences. Therefore, one CHZMA assay should be able to detect methylation in at least
10 genes and this throughput is 10 folds higher than that of MSP. Considering the fact
that CHZMA is sufficiently sensitive to detect 10% of methylated DNA, we believe that
CHZMA can be a good high-throughput method in place of MSP for methylation analysis
of tumor tissue samples.
Recently, a novel random whole-genome amplification method called BiMP was
developed to amplify bisulfite-treated DNA (Reinders et al. 2008). Unlike the standard
whole-genome method, BiMP reduces the length of the random primers from 6mers to
4mers to favor the priming of smaller DNA fragments. As a result, improved uniformity
of amplification of whole-genome was achieved. A combination of BiMP with CHZMA
may eventually offer a technology that allows for genome-wide, high-resolution DNA
methylation profiling using bisulfite-treated DNA.
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APPENDIX

The sequences of 32 Zip-Code
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32

TGGGTCCACAGTACCGCTGCAGA
CCGTGGGAGATTAGGTGGCTCAGA
GGGAATGGAGGTGGGAACGAGACA
CGCAAAGCAGACACAGGGTCGATT
GGGAGGCTGCTGTCCTTTCGATCA
AGACGCACCGCAACAGGCTGTCAA
TTGCAACGGGCTGGTCAACGTCAA
GCACCGATATGGAGACCGCAGACA
GGCTCGCAGGCTGGCTCATCCTAA
GGCTGCACCCGTTGAGGCACATCA
GTCCGTCCATGGCAAGCGTGATCA
ACAGCGTGTTCGTTGCTTGCATCA
CATCGCTGCAAGTACCGCACTCAA
GCACGGGAGCTGACGACGTGTCAA
CAAGGCACGTCCCAGACGCATCAA
CGCAGGTCGCTGCGTGTCCTGATT
GTCCCAAGTTGCGGCTCACTTTCG
AACGGGGAAGGTTGAGCGTGACAG
ATGGCGATGGTCCACTCGCAATCA
TTCGCCGTCGTGTAGGCTTTTCAA
CATCCAAGGTCCGACACGCAACGA
CGCATTCGATGGACAGGACATTCG
AAGCAAGCCAAGGTATGGCTTTGC
ACGAGGGATACCCGCAAACGATCA
CGTGGCTGACTCGCTGCGATGACA
CGCAATGGTAGGTGAGCAAGCAGA
ATGGCCGTGCTGGGGACAAGTCAA
GCTGGCTGGCACGCACCAGAATCA
CACTGCACACGAAACGGCACACAG
CGTGCGCACACTCACTGTCCTTCG
TTCGGCTGTTCGTAGGCAAGAGGT
GGCTGGGACGTGCAGACCGTTCAA
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